70385 Federal Register / Vol. 86, No. 235 / Friday, December 10, 2021 / Rules and Regulations 
more, the opportunity for this review 
already exists. When the Postal Service grants a mailer’s application for Periodicals mailing privileges, the Postal Service refunds to the mailer the difference between the Periodicals prices for the mailings made while the application was pending and the higher, non-Periodicals prices the mailer actually paid for those mailings (DMM 207.5.2.2b, 207.5.3.5). Any mailer whose application for Periodicals privileges is denied and who therefore does not receive this refund may appeal the denial (DMM 207.5.3.7). This appeal was available to the approximately 25 percent of 289 applications for Periodicals privileges denied by the Postal Service in FY 2020 and 2021. 
The Postal Service is revising the 
process to calculate pending postage by assigning the existing applicable class of mail prices based upon common characteristics of shape and weight. Each applicable class of mail price will be expressed as a percentage from the corresponding Periodicals price. This new process will simplify the calculation process during the authorization review period, and the refund process when a Periodicals publication is approved. 
We believe this revision will provide 
customers with a more efficient and easier process. 
List of Subjects in 39 CFR Part 111 
Administrative practice and 
procedure, Postal Service. 
The Postal Service adopts the 
following changes to Mailing Standards 
of the United States Postal Service, Domestic Mail Manual (DMM), incorporated by reference in the Code of Federal Regulations. See 39 CFR 111.1. 
We will publish an appropriate 
amendment to 39 CFR part 111 to reflect these changes. 
Accordingly, 39 CFR part 111 is 
amended as follows: 
PART 111—[AMENDED] 
■1. The authority citation for 39 CFR 
part 111 continues to read as follows: 
Authority: 5 U.S.C. 552(a); 13 U.S.C. 301– 
307; 18 U.S.C. 1692–1737; 39 U.S.C. 101, 
401–404, 414, 416, 3001–3018, 3201–3220, 3401–3406, 3621, 3622, 3626, 3629, 3631– 3633, 3641, 3681–3685, and 5001. 
■2. Revise the Mailing Standards of the 
United States Postal Service, Domestic 
Mail Manual (DMM) as follows: 
Mailing Standards of the United States 
Postal Service, Domestic Mail Manual (DMM) 
* * * * * 200 Commercial Mail Letters, Flats, 
and Parcels 
* * * * * 
207 Periodicals 
* * * * * 
5.0 Applying for Periodicals 
Authorization 
* * * * * 
5.2 Mailing While Application 
Pending 
* * * * * 
[Renumber 5.2.3 and 5.2.4 as 5.2.4 
and 5.2.5, add new 5.2.3 to read as 
follows:] 
5.2.3 Pending Postage 
Postage for a Periodicals publication 
pending authorization is calculated by 
applying the applicable percent in Exhibit 5.2.3 to PS Form 3541, Part P, Line P–1. 
Exhibit 5.2.3 Pending Postage 
Pending class of mail Percent 
USPS Marketing Mail Letters .................. * 00 
USPS Marketing Mail Flats ..................... 63 
Nonprofit USPS Marketing Mail Letters .. * 00 
Nonprofit USPS Marketing Mail Flats ..... 40 
Nonprofit USPS Marketing Mail Parcels 136 
Bound Printed Matter Flats ..................... 146 
Bound Printed Matter Parcels ................. * 00 
Parcel Select Parcels .............................. 585 
First-Class Mail Letters ........................... 95 
First-Class Mail Flats ............................... 427 
First-Class Package Service-R ............... 311 
Priority Mail ............................................. 545 
* Use Periodicals prices. 
* * * * * 
Ruth B. Stevenson, 
Chief Counsel, Ethics and Legal Compliance. 
[FR Doc. 2021–26716 Filed 12–7–21; 11:15 am] 
BILLING CODE P 
ENVIRONMENTAL PROTECTION 
AGENCY 
40 CFR Parts 9 and 721 
[EPA–HQ–OPPT–2020–0131; FRL–7842–02– 
OCSPP] 
RIN 2070–AB27 
Significant New Use Rules on Certain 
Chemical Substances (20–2.5e) 
AGENCY : Environmental Protection 
Agency (EPA). 
ACTION : Final rule. 
SUMMARY : EPA is issuing significant new 
use rules (SNURs) under the Toxic Substances Control Act (TSCA) for chemical substances that were the subject of premanufacture notices (PMNs). The SNURs require persons who intend to manufacture (defined by 
statute to include import) or process any of these chemical substances for an activity that is designated as a significant new use by this rule to notify EPA at least 90 days before commencing that activity. The required notification initiates EPA’s evaluation of the use, under the conditions of use for that chemical substance, within the applicable review period. Persons may not commence manufacture or processing for the significant new use until EPA has conducted a review of the notice, made an appropriate determination on the notice, and has taken such actions as are required by that determination. 
DATES : This rule is effective on February 
8, 2022. For purposes of judicial review, this rule shall be promulgated at 1 p.m. (e.s.t.) on December 27, 2021. 
FOR FURTHER INFORMATION CONTACT : For 
technical information contact: William Wysong, New Chemicals Division (7405M), Office of Pollution Prevention and Toxics, Environmental Protection Agency, 1200 Pennsylvania Ave. NW, Washington, DC 20460–0001; telephone number: (202) 564–4163; email address: wysong.william@epa.gov. For general 
information contact: The TSCA-Hotline, ABVI-Goodwill, 422 South Clinton Ave., Rochester, NY 14620; telephone number: (202) 554–1404; email address: TSCA-Hotline@epa.gov. 
SUPPLEMENTARY INFORMATION : 
I. General Information 
A. Does this action apply to me? 
You may be potentially affected by 
this action if you manufacture, process, 
or use the chemical substances contained in this rule. The following list of North American Industrial Classification System (NAICS) codes is not intended to be exhaustive, but rather provides a guide to help readers determine whether this document applies to them. Potentially affected entities may include: 
•Manufacturers or processors of one 
or more subject chemical substances (NAICS codes 325 and 324110), e.g., chemical manufacturing and petroleum refineries. 
This action may also affect certain 
entities through pre-existing import certification and export notification rules under TSCA. Chemical importers are subject to the TSCA section 13 (15 U.S.C. 2612) import provisions promulgated at 19 CFR 12.118 through 12.127 and 19 CFR 127.28. Chemical importers must certify that the shipment of the chemical substance complies with all applicable rules and Orders under TSCA, which would include the SNUR 
VerDate Sep<11>2014 15:55 Dec 09, 2021 Jkt 256001 PO 00000 Frm 00037 Fmt 4700 Sfmt 4700 E:\FR\FM\10DER1.SGM 10DER1jspears on DSK121TN23PROD with RULES170386 Federal Register / Vol. 86, No. 235 / Friday, December 10, 2021 / Rules and Regulations 
requirements. The EPA policy in 
support of import certification appears at 40 CFR part 707, subpart B. In addition, any persons who export or intend to export a chemical substance that is the subject of this rule are subject to the export notification provisions of TSCA section 12(b) (15 U.S.C. 2611(b)) (see 40 CFR 721.20), and must comply with the export notification requirements in 40 CFR part 707, subpart D. 
B. How can I access the dockets? 
The dockets include information 
considered by the Agency in developing 
the proposed and final rules. The docket for this action, identified by docket identification (ID) number EPA–HQ– OPPT–2020–0131, is available at https://www.regulations.gov and at the 
Office of Pollution Prevention and Toxics Docket (OPPT Docket), Environmental Protection Agency Docket Center (EPA/DC), West William 
Jefferson Clinton Bldg., Rm. 3334, 1301 Constitution Ave. NW, Washington, DC. The Public Reading Room is open from 8:30 a.m. to 4:30 p.m., Monday through Friday, excluding legal holidays. The telephone number for the Public Reading Room is (202) 566–1744, and the telephone number for the OPPT Docket is (202) 566–0280. 
Due to the public health concerns 
related to COVID–19, the EPA Docket Center (EPA/DC) and Reading Room is closed to visitors with limited exceptions. The staff continues to provide remote customer service via email, phone, and webform. For the latest status information on EPA/DC services and docket access, visit https:// 
www.epa.gov/dockets. 
II. Background 
A. What action is the Agency taking? 
EPA is finalizing SNURs under TSCA 
section 5(a)(2) for certain chemical 
substances which were the subject of PMNs. EPA will address the other proposed SNURs in future FR notices. 
Previously, EPA proposed SNURs for 
these chemical substances and established the record for these SNURs in the following Federal Register and docket ID number: 
•October 9, 2020 (85 FR 64280) 
(FRL–10011–86); Docket ID No. EPA– HQ–OPPT–2020–0131. 
The dockets include information 
considered by the Agency in developing the proposed and final rules, including public comments and EPA’s responses to the public comments received. B. What is the Agency’s authority for 
taking this action? 
TSCA section 5(a)(2) (15 U.S.C. 
2604(a)(2)) authorizes EPA to determine that a use of a chemical substance is a ‘‘significant new use.’’ EPA must make this determination by rule after considering all relevant factors, including the four bulleted TSCA section 5(a)(2) factors listed in Unit III. 
C. Applicability of General Provisions 
General provisions for SNURs appear 
in 40 CFR part 721, subpart A. These 
provisions describe persons subject to the rule, recordkeeping requirements, exemptions to reporting requirements, 
and applicability of the rule to uses occurring before the effective date of the rule. Provisions relating to user fees appear at 40 CFR part 700. Pursuant to 40 CFR 721.1(c), persons subject to these SNURs must comply with the significant new use notice (SNUN) requirements and EPA regulatory procedures as submitters of PMNs under TSCA section 5(a)(1)(A). In particular, these requirements include the information submission requirements of TSCA sections 5(b) and 5(d)(1), the exemptions authorized by TSCA sections 5(h)(1), (h)(2), (h)(3), and (h)(5), and the regulations at 40 CFR part 720. Once EPA receives a SNUN and before the manufacture or processing for the significant new use can commence, EPA must either determine that the significant new use is not likely to present an unreasonable risk of injury or take such regulatory action as is associated with an alternative determination. If EPA determines that the significant new use is not likely to present an unreasonable risk, EPA is required under TSCA section 5(g) to make public, and submit for publication in the Federal Register, a statement of EPA’s findings. 
III. Significant New Use Determination A. Considerations for Significant New 
Use Determinations 
When the Agency issues an order 
under TSCA section 5(e), section 5(f)(4) requires that the Agency consider whether to promulgate a SNUR for any use not conforming to the restrictions of the TSCA Order or publish a statement describing the reasons for not initiating the rulemaking. TSCA section 5(a)(2) states that EPA’s determination that a use of a chemical substance is a significant new use must be made after consideration of all relevant factors, including: 
•The projected volume of 
manufacturing and processing of a chemical substance. •The extent to which a use changes 
the type or form of exposure of human 
beings or the environment to a chemical substance. 
•The extent to which a use increases 
the magnitude and duration of exposure of human beings or the environment to a chemical substance. 
•The reasonably anticipated manner 
and methods of manufacturing, processing, distribution in commerce, and disposal of a chemical substance. 
In determining what would constitute 
a significant new use for the chemical substances that are the subject of these SNURs, EPA considered relevant information about the toxicity of the chemical substances, and potential human exposures and environmental releases that may be associated with possible uses of these chemical substances, in the context of the four bulleted TSCA section 5(a)(2) factors listed in this unit. 
B. Procedures for Significant New Uses 
Claimed as CBI 
By this rule, EPA is establishing 
certain significant new uses which have been claimed as CBI subject to Agency confidentiality regulations at 40 CFR part 2 and 40 CFR part 720, subpart E. Absent a final determination or other disposition of the confidentiality claim under 40 CFR part 2 procedures, EPA is required to keep this information confidential. EPA promulgated a procedure to deal with the situation where a specific significant new use is CBI, at 40 CFR 721.1725(b)(1) and has referenced it to apply to other SNURs. 
Under these procedures a 
manufacturer or processor may request EPA to determine whether a specific use would be a significant new use under the rule. The manufacturer or processor must show that it has a bona fide intent to manufacture or process the chemical substance and must identify the specific use for which it intends to manufacture or process the chemical substance. If EPA concludes that the person has shown a bona fide intent to manufacture or process the chemical substance, EPA will tell the person whether the use identified in the bona fide submission would be a significant new use under the rule. Since most of the chemical identities of the chemical substances subject to these SNURs are also CBI, manufacturers and processors can combine the bona fide submission under the procedure in 40 CFR 721.1725(b)(1) with that under 40 CFR 721.11 into a single step. 
If EPA determines that the use 
identified in the bona fide submission would not be a significant new use, i.e., the use does not meet the criteria 
VerDate Sep<11>2014 15:55 Dec 09, 2021 Jkt 256001 PO 00000 Frm 00038 Fmt 4700 Sfmt 4700 E:\FR\FM\10DER1.SGM 10DER1jspears on DSK121TN23PROD with RULES170387 Federal Register / Vol. 86, No. 235 / Friday, December 10, 2021 / Rules and Regulations 
specified in the rule for a significant 
new use, that person can manufacture or process the chemical substance so long as the significant new use trigger is not met. In the case of a production volume trigger, this means that the aggregate annual production volume does not exceed that identified in the bona fide submission to EPA. Because of confidentiality concerns, EPA does not typically disclose the actual production volume that constitutes the use trigger. Thus, if the person later intends to exceed that volume, a new bona fide submission would be necessary to determine whether that higher volume would be a significant new use. 
IV. Public Comments on Proposed Rule 
and EPA Responses 
EPA received public comments from 
three identifying entities on the proposed rules. The Agency’s responses are presented in the Response to Public Comments document that is available in the public docket for this rulemaking. In addition, EPA received three anonymous comments. The anonymous comments were either general in nature and did not pertain to the proposed rule or were broadly supportive of the rule and requested no changes to the rule itself; therefore, no response is required. EPA made changes to 27 of the proposed rules as described in the response to comments. 
V. Substances Subject to This Rule 
EPA is establishing significant new 
use and recordkeeping requirements for 
chemical substances in 40 CFR part 721, subpart E. In Unit IV. of the proposed SNURs, EPA provided the following information for each chemical substance: 
•PMN number. 
•Chemical name (generic name, if 
the specific name is claimed as confidential business information (CBI)). 
•Chemical Abstracts Service (CAS) 
Registry number (if assigned for non- confidential chemical identities). 
•Effective date of and basis for the 
TSCA Order. 
•Potentially Useful Information. This 
is information identified by EPA that would help characterize the potential health and/or environmental effects of the chemical substances if a manufacturer or processor is considering submitting a SNUN for a significant new use designated by the SNUR. 
•CFR citation assigned in the 
regulatory text section of these rules. 
The regulatory text section of these 
rules specifies the activities designated as significant new uses. Certain new uses, including production volume limits and other uses designated in the rules, may be claimed as CBI. 
These final rules include PMN 
substances that are subject to orders issued under TSCA section 5(e)(1)(A), as required by the determinations made under TSCA section 5(a)(3)(B). Those TSCA Orders require protective measures to limit exposures or otherwise mitigate the potential unreasonable risk. The final SNURs identify as significant new uses any manufacturing, processing, use, distribution in commerce, or disposal that does not conform to the restrictions imposed by the underlying TSCA Orders, consistent with TSCA section 5(f)(4). 
Where EPA determined that the PMN 
substance may present an unreasonable risk of injury to human health via inhalation exposure, the underlying TSCA Order usually requires that potentially exposed employees wear specified respirators unless actual measurements of the workplace air show that air-borne concentrations of the PMN substance are below a New Chemical Exposure Limit (NCEL). The comprehensive NCELs provisions in TSCA Orders include requirements addressing performance criteria for sampling and analytical methods, periodic monitoring, respiratory protection, and recordkeeping. No comparable NCEL provisions currently exist in 40 CFR part 721, subpart B, for SNURs. Therefore, for these cases, the individual SNURs in 40 CFR part 721, subpart E, will state that persons subject to the SNUR who wish to pursue NCELs as an alternative to the 40 CFR 721.63 respirator requirements may request to do so under 40 CFR 721.30. EPA expects that persons whose 40 CFR 721.30 requests to use the NCELs approach for SNURs that are approved by EPA will be required to comply with NCELs provisions that are comparable to those contained in the corresponding TSCA Order. 
VI. Rationale and Objectives of the Rule A. Rationale 
During review of the PMNs submitted 
for the chemical substances that are 
subject to these SNURs and as further discussed in Unit IV. of the proposed rules, EPA concluded that regulation was warranted under TSCA section 5(e), pending the development of information sufficient to make reasoned evaluations of the health or environmental effects of the chemical substances. Based on such findings, TSCA Orders requiring the use of appropriate exposure controls were negotiated with the PMN submitters. As a general matter, EPA believes it is 
necessary to follow TSCA Orders with a SNUR that identifies the absence of those protective measures as significant new uses to ensure that all manufacturers and processors—not just the original submitter—are held to the same standard. 
B. Objectives 
EPA is issuing these SNURs because 
the Agency wants to: 
•Receive notice of any person’s 
intent to manufacture or process a listed 
chemical substance for the described significant new use before that activity begins. 
•Have an opportunity to review and 
evaluate data submitted in a SNUN before the notice submitter begins manufacturing or processing a listed chemical substance for the described significant new use; and 
•Be obligated to make a 
determination under TSCA section 5(a)(3) regarding the use described in the SNUN, under the conditions of use. The Agency will either determine under TSCA section 5(a)(3)(C) that significant new use is not likely to present an unreasonable risk, including an unreasonable risk to a potentially exposed or susceptible subpopulation identified as relevant by the Administrator under the conditions of use, or make a determination under TSCA section 5(a)(3)(A) or (B) and take the required regulatory action associated with the determination, before manufacture or processing for the significant new use of the chemical substance can occur. 
Issuance of a SNUR for a chemical 
substance does not signify that the chemical substance is listed on the TSCA Chemical Substance Inventory (TSCA Inventory). Guidance on how to determine if a chemical substance is on the TSCA Inventory is available on the internet at https://www.epa.gov/tsca- inventory. 
VII. Applicability of the Significant 
New Use Designation 
To establish a significant new use, 
EPA must determine that the use is not ongoing. The chemical substances subject to this rule have undergone premanufacture review. In cases where EPA has not received a notice of commencement (NOC) and the chemical substance has not been added to the TSCA Inventory, no person may commence such activities without first submitting a PMN. Therefore, for chemical substances for which an NOC has not been submitted, EPA concludes that the designated significant new uses are not ongoing. 
VerDate Sep<11>2014 15:55 Dec 09, 2021 Jkt 256001 PO 00000 Frm 00039 Fmt 4700 Sfmt 4700 E:\FR\FM\10DER1.SGM 10DER1jspears on DSK121TN23PROD with RULES170388 Federal Register / Vol. 86, No. 235 / Friday, December 10, 2021 / Rules and Regulations 
When chemical substances identified 
in this rule are added to the TSCA 
Inventory, EPA recognizes that, before the rule is effective, other persons might engage in a use that has been identified as a significant new use. However, TSCA Orders have been issued for all the chemical substances that are the subject of this rule, and the PMN submitters are prohibited by the TSCA Orders from undertaking activities which will be designated as significant new uses. The identities of many of the chemical substances subject to this rule have been claimed as confidential (per 40 CFR 720.85). Based on this, the Agency believes that it is highly unlikely that any of the significant new uses described in the regulatory text of this rule are ongoing. 
Furthermore, EPA designated the 
publication dates of the proposed rules (see Unit II.) as the cutoff dates for determining whether the new uses are ongoing. The objective of EPA’s approach has been to ensure that a person could not defeat a SNUR by initiating a significant new use before the effective date of the final rule. 
In the unlikely event that a person 
began commercial manufacture or processing of the chemical substances for a significant new use identified as of the abovementioned dates, that person will have to cease any such activity upon the effective date of the final rule. To resume their activities, that person would have to first comply with all applicable SNUR notification 
requirements and wait until EPA has conducted a review of the notice, made an appropriate determination on the notice, and has taken such actions as are required with that determination. 
VIII. Development and Submission of 
Information 
EPA recognizes that TSCA section 5 
does not require development of any particular new information (e.g., generating test data) before submission of a SNUN. There is an exception: If a person is required to submit information for a chemical substance pursuant to a rule, TSCA Order or consent agreement under TSCA section 4, then TSCA section 5(b)(1)(A) requires such information to be submitted to EPA at the time of submission of the SNUN. 
In the absence of a rule, TSCA Order, 
or consent agreement under TSCA section 4 covering the chemical substance, persons are required only to submit information in their possession or control and to describe any other information known to them or reasonably ascertainable by them (see 40 CFR 720.50). However, upon review of PMNs and SNUNs, the Agency has the authority to require appropriate testing. 
Unit IV. of the proposed rule lists potentially useful information for all SNURs listed in this document. Descriptions are provided for informational purposes. The information identified in Unit IV. of the proposed rule will be potentially useful to EPA’s evaluation in the event that someone submits a SNUN for the significant new use. Companies who are considering submitting a SNUN are encouraged, but not required, to develop the information on the substance. 
EPA strongly encourages persons, 
before performing any testing, to consult with the Agency. Furthermore, pursuant to TSCA section 4(h), which pertains to reduction of testing in vertebrate animals, EPA encourages consultation with the Agency on the use of alternative test methods and strategies (also called New Approach Methodologies, or NAMs), if available, to generate the recommended test data. EPA encourages dialog with Agency representatives to help determine how best the submitter can meet both the data needs and the objective of TSCA section 4(h). For more information on alternative test methods and strategies to reduce vertebrate animal testing, visit https://www.epa.gov/assessing-and- managing-chemicals-under-tsca/ alternative-test-methods-and-strategies- reduce. 
In some of the TSCA Orders for the 
chemical substances identified in this rule, EPA has established production volume and time limits in view of the lack of data on the potential health and environmental risks that may be posed by the significant new uses or increased exposure to the chemical substances. These limits cannot be exceeded unless the PMN submitter first submits the results of specified tests that would permit a reasoned evaluation of the potential risks posed by these chemical substances. The SNURs contain the same limits as the TSCA Orders. Exceeding these production limits is defined as a significant new use. Persons who intend to exceed the production limit must notify the Agency by submitting a SNUN at least 90 days in advance of commencement of non- exempt commercial manufacture or processing. 
Any request by EPA for the triggered 
and pended testing described in the 
TSCA Orders was made based on EPA’s consideration of available screening- level data, if any, as well as other available information on appropriate testing for the PMN substances. Further, any such testing request on the part of EPA that includes testing on vertebrates was made after consideration of available toxicity information, 
computational toxicology and bioinformatics, and high-throughput screening methods and their prediction models. 
The potentially useful information 
identified in Unit IV. of the proposed rule may not be the only means of addressing the potential risks of the chemical substance associated with the designated significant new uses. However, submitting a SNUN without any test data or other information may increase the likelihood that EPA will take action under TSCA sections 5(e) or 5(f). EPA recommends that potential SNUN submitters contact EPA early enough so that they will be able to conduct the appropriate tests. 
SNUN submitters should be aware 
that EPA will be better able to evaluate SNUNs that provide detailed information on the following: 
•Human exposure and 
environmental release that may result from the significant new use of the chemical substances. 
•Information on risks posed by the 
chemical substances compared to risks posed by potential substitutes. 
IX. SNUN Submissions 
According to 40 CFR 721.1(c), persons 
submitting a SNUN must comply with 
the same notification requirements and EPA regulatory procedures as persons submitting a PMN, including submission of test data on health and environmental effects as described in 40 CFR 720.50. SNUNs must be submitted on EPA Form No. 7710–25, generated using e-PMN software, and submitted to the Agency in accordance with the procedures set forth in 40 CFR 720.40 and 721.25. E–PMN software is available electronically at https://www.epa.gov/reviewing-new-chemicals- under-toxic-substances-control-act-tsca. 
X. Economic Analysis 
EPA has evaluated the potential costs 
of establishing SNUN requirements for 
potential manufacturers and processors of the chemical substances subject to this rule. EPA’s complete economic analyses are available in each docket listed in Unit II. 
XI. Statutory and Executive Order 
Reviews 
Additional information about these 
statutes and Executive Orders can be found at https://www.epa.gov/laws- regulations-and-executive-orders. 
VerDate Sep<11>2014 15:55 Dec 09, 2021 Jkt 256001 PO 00000 Frm 00040 Fmt 4700 Sfmt 4700 E:\FR\FM\10DER1.SGM 10DER1jspears on DSK121TN23PROD with RULES170389 Federal Register / Vol. 86, No. 235 / Friday, December 10, 2021 / Rules and Regulations 
A. Executive Order 12866: Regulatory 
Planning and Review and Executive Order 13563: Improving Regulations and Regulatory Review 
This action establishes SNURs for 
several new chemical substances that were the subject of PMNs. The Office of Management and Budget (OMB) has exempted these types of actions from review under Executive Orders 12866 (58 FR 51735, October 4, 1993) and 13563 (76 FR 3821, January 21, 2011). 
B. Executive Order 13771: Reducing 
Regulations and Controlling Regulatory Costs 
This action is not subject to Executive 
Order 13771 (82 FR 9339, February 3, 2017), because this action is not a significant regulatory action under Executive Order 12866. 
C. Paperwork Reduction Act (PRA) 
According to the PRA (44 U.S.C. 3501 
et seq.), an agency may not conduct or 
sponsor, and a person is not required to respond to a collection of information that requires OMB approval under PRA, unless it has been approved by OMB and displays a currently valid OMB control number. The information collection requirements associated with SNURs have already been approved by OMB pursuant to the PRA under OMB control number 2070–0012 (EPA ICR No. 574). This rule does not impose any burden requiring additional OMB approval. 
The OMB control numbers for EPA’s 
regulations in title 40 of the CFR, after appearing in the Federal Register, are listed in 40 CFR part 9, and included on the related collection instrument or form, if applicable. EPA is amending the table in 40 CFR part 9 to list the OMB approval number for the information collection requirements contained in this action. This listing of the OMB control numbers and their subsequent codification in the CFR satisfies the display requirements of PRA and OMB’s implementing regulations at 5 CFR part 1320. The Information Collection Request (ICR) covering the SNUR activities was previously subject to public notice and comment prior to OMB approval, and given the technical nature of the table, EPA finds that further notice and comment to amend it is unnecessary. As a result, EPA finds that there is ‘‘good cause’’ under section 553(b)(3)(B) of the Administrative Procedure Act (5 U.S.C. 553(b)(3)(B)) to amend this table without further notice and comment. 
If an entity were to submit a SNUN to 
the Agency, the annual burden is estimated to average between 30 and 170 hours per response. This burden 
estimate includes the time needed to review instructions, search existing data sources, gather and maintain the data needed, and complete, review, and submit the required SNUN. 
Send any comments about the 
accuracy of the burden estimate, and any suggested methods for minimizing respondent burden, including through the use of automated collection techniques, to the Director, Regulatory Support Division, Office of Mission Support (2822T), Environmental Protection Agency, 1200 Pennsylvania Ave. NW, Washington, DC 20460–0001. Please remember to include the OMB control number in any correspondence, but do not submit any completed forms to this address. 
D. Regulatory Flexibility Act (RFA) 
Pursuant to the RFA section 605(b) (5 
U.S.C. 601 et seq.), the Agency hereby 
certifies that promulgation of these SNURs would not have a significant adverse economic impact on a substantial number of small entities. The requirement to submit a SNUN applies to any person (including small or large entities) who intends to engage in any activity described in the final rule as a ‘‘significant new use.’’ Because these uses are ‘‘new,’’ based on all information currently available to EPA, EPA has concluded that no small or large entities presently engage in such activities. A SNUR requires that any person who intends to engage in such activity in the future must first notify EPA by submitting a SNUN. Although some small entities may decide to pursue a significant new use in the future, EPA cannot presently determine how many, if any, there may be. However, EPA’s experience to date is that, in response to the promulgation of SNURs covering over 1,000 chemicals, the Agency receives only a small number of notices per year. For example, EPA received 7 SNUNs in Federal fiscal year (FY) 2013, 13 in FY2014, 6 in FY2015, 10 in FY2016, 14 in FY2017, and 11 in FY2018 and only a fraction of these were from small businesses. In addition, the Agency currently offers relief to qualifying small 
businesses by reducing the SNUN submission fee from $16,000 to $2,800. This lower fee reduces the total reporting and recordkeeping of cost of submitting a SNUN to about $10,116 for qualifying small firms. Therefore, the potential economic impacts of complying with this SNUR are not expected to be significant or adversely impact a substantial number of small entities. In a SNUR that published in the Federal Register of June 2, 1997 (62 FR 29684) (FRL–5597–1), the Agency presented its general determination that final SNURs are not expected to have a significant economic impact on a substantial number of small entities, which was provided to the Chief Counsel for Advocacy of the Small Business Administration. 
E. Unfunded Mandates Reform Act 
(UMRA) 
Based on EPA’s experience with 
proposing and finalizing SNURs, State, local, and Tribal governments have not been impacted by these rulemakings, and EPA does not have any reasons to believe that any State, local, or Tribal government will be impacted by this action. As such, EPA has determined that this action does not impose any enforceable duty, contain any unfunded mandate, or otherwise have any effect on small governments subject to the requirements of UMRA sections 202, 203, 204, or 205 (2 U.S.C. 1501 et seq.). 
F. Executive Order 13132: Federalism 
This action will not have a substantial 
direct effect on States, on the 
relationship between the National Government and the States, or on the distribution of power and responsibilities among the various levels of government, as specified in Executive Order 13132 (64 FR 43255, August 10, 1999). 
G. Executive Order 13175: Consultation 
and Coordination With Indian Tribe Governments 
This action does not have Tribal 
implications because it is not expected to have substantial direct effects on Indian Tribes. This action does not significantly nor uniquely affect the communities of Indian Tribal governments, nor does it involve or impose any requirements that affect Indian Tribes. Accordingly, the requirements of Executive Order 13175 (65 FR 67249, November 9, 2000), do not apply to this action. 
H. Executive Order 13045: Protection of 
Children From Environmental Health Risks and Safety Risks 
This action is not subject to Executive 
Order 13045 (62 FR 19885, April 23, 1997), because this is not an economically significant regulatory action as defined by Executive Order 12866, and this action does not address environmental health or safety risks disproportionately affecting children. EPA interprets Executive Order 13045 as applying only to those regulatory actions that concern environmental health or safety risks that EPA has reason to believe may 
VerDate Sep<11>2014 15:55 Dec 09, 2021 Jkt 256001 PO 00000 Frm 00041 Fmt 4700 Sfmt 4700 E:\FR\FM\10DER1.SGM 10DER1jspears on DSK121TN23PROD with RULES170390 Federal Register / Vol. 86, No. 235 / Friday, December 10, 2021 / Rules and Regulations 
disproportionately affect children, per 
the definition of ‘‘covered regulatory action’’ in section 2–202 of the Executive Order. 
I. Executive Order 13211: Actions 
Concerning Regulations That Significantly Affect Energy Supply, Distribution, or Use 
This action is not subject to Executive 
Order 13211 (66 FR 28355, May 22, 2001), because this action is not expected to affect energy supply, distribution, or use and because this action is not a significant regulatory action under Executive Order 12866. 
J. National Technology Transfer and 
Advancement Act (NTTAA) 
In addition, since this action does not 
involve any technical standards subject to NTTAA section 12(d) (15 U.S.C. 272 note). 
K. Executive Order 12898: Federal 
Actions To Address Environmental Justice in Minority Populations and Low-Income Populations 
This action does not entail special 
considerations of environmental justice related issues as delineated by Executive Order 12898 (59 FR 7629, February 16, 1994). 
L. Congressional Review Act (CRA) 
This action is subject to the CRA, 5 
U.S.C. 801 et seq., and EPA will submit 
a rule report containing this rule and other required information to each House of the Congress and to the Comptroller General of the United States. This action is not a ‘‘major rule’’ as defined by 5 U.S.C. 804(2). 
List of Subjects 40 CFR Part 9 
Environmental protection, Reporting 
and recordkeeping requirements. 40 CFR Part 721 
Environmental protection, Chemicals, 
Hazardous substances, Reporting and 
recordkeeping requirements. 
Dated: December 3, 2021. 
Tala Henry, 
Deputy Director, Office of Pollution 
Prevention and Toxics. 
Therefore, for the reasons stated in the 
preamble, 40 CFR chapter I is amended 
as follows: 
PART 9—OMB APPROVALS UNDER 
THE PAPERWORK REDUCTION ACT 
■1. The authority citation for part 9 
continues to read as follows: 
Authority: 7 U.S.C. 135 et seq., 136–136y; 
15 U.S.C. 2001, 2003, 2005, 2006, 2601–2671; 21 U.S.C. 331j, 346a; 31 U.S.C. 9701; 33 
U.S.C. 1251 et seq., 1311, 1313d, 1314, 1318, 1321, 1326, 1330, 1342, 1344, 1345 (d) and (e), 1361; E.O. 11735, 38 FR 21243, 3 CFR, 1971–1975 Comp. p. 973; 42 U.S.C. 241, 242b, 243, 246, 300f, 300g, 300g–1, 300g–2, 300g–3, 300g–4, 300g–5, 300g–6, 300j–1, 300j–2, 300j–3, 300j–4, 300j–9, 1857 et seq., 6901–6992k, 7401–7671q, 7542, 9601–9657, 11023, 11048. 
■2. In § 9.1, amend the table by adding 
entries for §§ 721.11401 through 
721.11403 and §§ 721.11514 through 721.11555 in numerical order under the undesignated center heading ‘‘Significant New Uses of Chemical Substances’’ to read as follows: 
§ 9.1 OMB approvals under the Paperwork 
Reduction Act. 
* * * * * 
40 CFR citation OMB control No. 
*****  
Significant New Uses of Chemical 
Substances 
*****  
721.11401 ....................... 2070–0012 
721.11402 ....................... 2070–0012 721.11403 ....................... 2070–0012 
*****  
721.11514 ....................... 2070–0012 721.11515 ....................... 2070–0012 721.11516 ....................... 2070–0012 721.11517 ....................... 2070–0012 721.11518 ....................... 2070–0012 721.11519 ....................... 2070–0012 721.11520 ....................... 2070–0012 721.11521 ....................... 2070–0012 721.11522 ....................... 2070–0012 721.11523 ....................... 2070–0012 721.11524 ....................... 2070–0012 721.11525 ....................... 2070–0012 721.11526 ....................... 2070–0012 721.11527 ....................... 2070–0012 
721.11528 ....................... 2070–0012 721.11529 ....................... 2070–0012 721.11530 ....................... 2070–0012 721.11531 ....................... 2070–0012 721.11532 ....................... 2070–0012 721.11533 ....................... 2070–0012 721.11534 ....................... 2070–0012 721.11535 ....................... 2070–0012 721.11536 ....................... 2070–0012 721.11537 ....................... 2070–0012 721.11538 ....................... 2070–0012 721.11539 ....................... 2070–0012 721.11540 ....................... 2070–0012 721.11541 ....................... 2070–0012 721.11542 ....................... 2070–0012 721.11543 ....................... 2070–0012 721.11544 ....................... 2070–0012 721.11545 ....................... 2070–0012 721.11546 ....................... 2070–0012 721.11547 ....................... 2070–0012 721.11548 ....................... 2070–0012 721.11549 ....................... 2070–0012 721.11550 ....................... 2070–0012 721.11551 ....................... 2070–0012 40 CFR citation OMB control No. 
721.11552 ....................... 2070–0012 721.11553 ....................... 2070–0012 721.11554 ....................... 2070–0012 721.11555 ....................... 2070–0012 721.11443 ....................... 2070–0012 
*****  
* * * * * 
PART 721—SIGNIFICANT NEW USES 
OF CHEMICAL SUBSTANCES 
■3. The authority citation for part 721 
continues to read as follows: 
Authority: 15 U.S.C. 2604, 2607, and 
2625(c). 
■4. Add §§ 721.11401 through 
721.11403 and §§ 721.11514 through 721.11555 in numerical order to subpart E to read as follows: 
Subpart E—Significant New Uses for 
Specific Chemical Substances 
Sec. 
* * * * * 
721.11401 2-Propenoic acid, 2-methyl-, 
methyl ester, polymer with 
ethenylbenzene, ethyl 2-propenoate, 2- oxiranylmethyl 2-methyl-2-propenoate and 1,2-propanediol mono(2-methyl-2- propenoate), reaction products with diethanolamine, polymers with substituted-alkyl acrylate, formats (salts) (generic). 
721.11402 2-Propenoic acid, 2-methyl, 
methyl ester, polymer with ethenylbenzene, ethyl 2-propenoate, 2- oxiranylmethyl 2-methyl-2-propenoate and 1,2-propanediol mono(2-methyl-2- propenoate), reaction products with diethanolamine, polymers with substituted-alkyl methacrylate, formats (salts) (generic). 
721.11403 2-Propenoic acid, 2-methyl-, 
methyl ester, polymer with ethenylbenzene, ethyl 2-propenoate, 2- oxrianylmethyl 2-methyl-2-propenoate, and 1,2-propaneidol mono(2-methyl-2- propenoate), reaction products with diethanolamine, polymers with alkylene glycol monoacrylate, formats (salts) (generic). 
* * * * * 
721.11514 Organic sulfonate compound 
(generic). 
721.11515 Thiophenium, 1-(2,7- 
disubstituted-1-naphthalenyl)tetrahydro- , salt with polyfluoro-N- polyfluoroalkylsulfonyl-1- alkanesulfonamide (1:1) (generic). 
721.11516 Sulfonium, triphenyl-, salt with 
2,3-bis(substituted) 5- sulfocarbopolycyclic-2,3-carboxylate derivative (1:1) (generic). 
721.11517 Thiophenium, 1-(2,7- 
disubstituted-1-naphthalenyl)tetrahydro- , salt with polyfluoro-N- polyfluoroalkylsulfonyl-1- alkanesulfonamide (1:1) (generic). 
VerDate Sep<11>2014 15:55 Dec 09, 2021 Jkt 256001 PO 00000 Frm 00042 Fmt 4700 Sfmt 4700 E:\FR\FM\10DER1.SGM 10DER1jspears on DSK121TN23PROD with RULES170391 Federal Register / Vol. 86, No. 235 / Friday, December 10, 2021 / Rules and Regulations 
721.11518 Sulfonium, triphenyl-, 5-(alkyl) 
fluoropentane derivative (generic). 
721.11519 Sulfonium, triphenyl-, salt with 
substituted-alkyl 4-substituted-benzoate 
(generic). 
721.11520 Substituted-triphenylsulfonium, 
inner salt (generic). 
721.11521 Sulfonium, triphenyl-, salt with 
disubstituted-heterocyclic compound (1:1) (generic). 
721.11522 Sulfonium, triphenyl-, salt with 
2,4,5-trisubstituted-benzenesulfonate (1:1) (generic). 
721.11523 Substituted heterocyclic onium 
compound, salt with 2,2,2-trifluoro-1- (sulfomethyl)-1-(trifluoromethyl)ethyl 3- [(2-methyl-1-oxo-2-propen-1- yl)oxy]tricyclo[3.3.1.13,7]decane-1- carboxylate (1:1), polymer with acenaphthylene, 1-ethenyl-4-[(1- ethylcyclopentyl)oxy]benzene and 4- 
ethenylphenol, di-Me 2,2′-(1,2- diazenediyl)bis[2-methylpropanoate]- initiated (generic). 
721.11524 Substituted heterocyclic onium 
compound, salt with 2,2,2-trifluoro-1- (sulfomethyl)-1-(trifluoromethyl)ethyl 3- [(2-methyl-1-oxo-2-propen-1- yl)oxy]tricyclo[3.3.1.13,7]decane-1- carboxylate (1:1), polymer with acenaphthylene, 1-ethenyl-4-[[1-(1- methylethyl)cyclopentyl]oxy]benzene and 4-ethenylphenol, di-Me 2,2′-(1,2- diazenediyl)bis[2-methylpropanoate]- initiated (generic). 
721.11525 Dibenzothiophenium, aryl 
substituted trifluoro-hydroxy- (triheterosubstitutedalkyl)alkanoate (1:1) (generic). 
721.11526 Substituted heterocyclic onium 
compound, salt with 1- (difluorosulfomethyl)-2,2,2-trifluoroethyl 3-[(2-methyl-1-oxo-2-propen-1- yl)oxy]tricyclo[3.3.1.13,7]decane-1- carboxylate (1:1), polymer with 3- ethenylphenol, 1-(1- methylethyl)cyclopentyl 2-methyl-2- propenoate and 1-(7- oxabicyclo[2.2.1]hept-2-yl)cyclopentyl 2- methyl-2-propenoate, di-Me 2,2′-(1,2- diazenediyl)bis[2-methylpropenoate]- initiated (generic). 
721.11527 Sulfonium, triphenyl-, trifluoro- 
hydroxy- (triheterosubstitutedalkyl)alkanoate (1:1) (generic). 
721.11528 Heterotrisubstituted-bile acid, 1- 
(difluorosulfomethyl)-2,2,2-trifluoroethyl ester, ion(1-), (5)-, triphenylsulfonium (1:1) (generic). 
721.11529 Aromatic sulfonium tricyclo 
fluoroalkyl sulfonic acid salt (generic) 
721.11530 Substituted, 
(alkylaromatic)diaromatic salt with trihalo- [(trihaloalkyl)substituted]substituted alkaneamide (generic). 
721.11531 Triarylsulfonium substituted 
oxatricycloalkyloxycarbonyl dihalo alkane sulfonate (generic). 
721.11532 Substituted triarylsulfonium 
carbopolycyclic heteromonocyclic dihalo sulfoacetate (generic). 
721.11533 Substituted triarylsulfonium 
substituted carbopolycyclic carboxylate (generic). 721.11534 Sulfonium, 
bis(dihalocarbomonocycle) 
carbomonocycle, salt with substituted heteropolycycle dihalo sulfoalkanoate (1:1) (generic). 
721.11535 Heteropolycycle, alkylaromatic-, 
salt with dihalo-substituted alkyl carbopolycycle carboxylate (generic). 
721.11536 Sulfonium, triaryl-, salt with 
polyhalo-4-sulfoalkyl polycarbocyclic alkane-1-carboxylate (1:1) (generic). 
721.11537 Sulfonium, 
bis(dihalocarbomonocycle) carbomonocycle, salt with dihalo substituted alkyl carbopolycyclic carboxylate (1:1) (generic). 
721.11538 Sulfonium, 
bis(dihalocarbomonocycle) carbomonocycle, substituted carbomonocyclic ester (generic). 
721.11539 Heteropolycycle, aromatic-, salt 
with dihalo-substituted alkyl carbopolycycle carboxylate (1:1) (generic). 
721.11540 Triarylsulfonium 
alkylestersulfonate (generic). 
721.11541 Halogenated alkylbenzoic acid 
(generic) (P–19–168). 
721.11542 Halogenated alkylbenzoic acid 
(generic) (P–19–169). 
721.11543 Halogenated benzoic acid 
(generic) (P–19–171). 
721.11544 Halogenated benzoic acid 
(generic) (P–19–172). 
721.11545 Halogenated benzoic acid 
(generic) (P–19–173). 
721.11546 Halogenated alkylbenzoic acid 
(generic) (P–19–175). 
721.11547 Halogenated alkylbenzoic acid 
(generic) (P–19–176). 
721.11548 Halogenated alkylbenzoic acid 
(generic) (P–19–177). 
721.11549 Halogenated alkylbenzoic acid 
(generic) (P–19–178). 
721.11550 Halogenated alkylbenzoic acid 
(generic) (P–19–179). 
721.11551 Halogenated sodium benzoate 
(generic) (P–19–180). 
721.11552 Halogenated sodium benzoate 
(generic) (P–19–181). 
721.11553 Halogenated sodium benzoate 
(generic) (P–19–182). 
721.11554 Halogenated sodium 
alkylbenzoate (generic) (P–19–184). 
721.11555 Halogenated sodium 
alkylbenzoate (generic) (P–19–187). 
* * * * * 
§ 721.11401 2-Propenoic acid, 2-methyl-, 
methyl ester, polymer with ethenylbenzene, ethyl 2-propenoate, 2-oxiranylmethyl 2- methyl-2-propenoate and 1,2-propanediol mono(2-methyl-2-propenoate), reaction products with diethanolamine, polymers with substituted-alkyl acrylate, formats (salts) (generic). 
(a) Chemical substance and 
significant new uses subject to reporting. 
(1) The chemical substance identified generically as 2-propenoic acid, 2- methyl-, methyl ester, polymer with ethenylbenzene, ethyl 2-propenoate, 2- oxiranylmethyl 2-methyl-2-propenoate and 1,2-propanediol mono(2-methyl-2- propenoate), reaction products with diethanolamine, polymers with substituted-alkyl acrylate, formats (salts) (PMN P–18–241) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. 
(2) The significant new uses are: 
(i) Industrial, commercial, and 
consumer activities. Requirements as 
specified in § 721.80(j). 
(ii) [Reserved] 
(b) Specific requirements. The 
provisions of subpart A of this part 
apply to this section except as modified by this paragraph (b). 
(1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125(a) through (c) and (i) are applicable to manufacturers and processors of this substance. 
(2) Limitation or revocation of certain 
notification requirements. The provisions of § 721.185 apply to this section. 
(3) Determining whether a specific use 
is subject to this section. The provisions of § 721.1725(b)(1) apply to paragraph (a)(2)(i) of this section. 
§ 721.11402 2-Propenoic acid, 2-methyl, 
methyl ester, polymer with ethenylbenzene, ethyl 2-propenoate, 2-oxiranylmethyl 2- methyl-2-propenoate and 1,2-propanediol mono(2-methyl-2-propenoate), reaction products with diethanolamine, polymers with substituted-alkyl methacrylate, formats (salts) (generic). 
(a) Chemical substance and 
significant new uses subject to reporting. 
(1) The chemical substance identified generically as 2-propenoic acid, 2- methyl, methyl ester, polymer with ethenylbenzene, ethyl 2-propenoate, 2- oxiranylmethyl 2-methyl-2-propenoate and 1,2-propanediol mono(2-methyl-2- propenoate), reaction products with diethanolamine, polymers with substituted-alkyl methacrylate, formats (salts) (PMN P–18–244) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. 
(2) The significant new uses are: 
(i) Industrial, commercial, and 
consumer activities. Requirements as 
specified in § 721.80(j). 
(ii) [Reserved] 
(b) Specific requirements. The 
provisions of subpart A of this part 
apply to this section except as modified by this paragraph (b). 
(1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125(a) through (c) and (i) are applicable to manufacturers and processors of this substance. 
(2) Limitation or revocation of certain 
notification requirements. The provisions of § 721.185 apply to this section. 
VerDate Sep<11>2014 15:55 Dec 09, 2021 Jkt 256001 PO 00000 Frm 00043 Fmt 4700 Sfmt 4700 E:\FR\FM\10DER1.SGM 10DER1jspears on DSK121TN23PROD with RULES170392 Federal Register / Vol. 86, No. 235 / Friday, December 10, 2021 / Rules and Regulations 
(3) Determining whether a specific use 
is subject to this section. The provisions 
of § 721.1725(b)(1) apply to paragraph 
(a)(2)(i) of this section. 
§ 721.11403 2-Propenoic acid, 2-methyl-, 
methyl ester, polymer with ethenylbenzene, ethyl 2-propenoate, 2-oxrianylmethyl 2- methyl-2-propenoate, and 1,2-propaneidol mono(2-methyl-2-propenoate), reaction products with diethanolamine, polymers with alkylene glycol monoacrylate, formats (salts) (generic). 
(a) Chemical substance and 
significant new uses subject to reporting. 
(1) The chemical substance identified generically as 2-propenoic acid, 2- methyl-, methyl ester, polymer with ethenylbenzene, ethyl 2-propenoate, 2- oxrianylmethyl 2-methyl-2-propenoate, and 1,2-propaneidol mono(2-methyl-2- propenoate), reaction products with diethanolamine, polymers with alkylene glycol monoacrylate, formats (salts) (PMN P–18–245) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. 
(2) The significant new uses are: 
(i) Industrial, commercial, and 
consumer activities. Requirements as 
specified in § 721.80(j). 
(ii) [Reserved] 
(b) Specific requirements. The 
provisions of subpart A of this part 
apply to this section except as modified by this paragraph (b). 
(1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125(a) through (c) and (i) are applicable to manufacturers and processors of this substance. 
(2) Limitation or revocation of certain 
notification requirements. The provisions of § 721.185 apply to this section. 
(3) Determining whether a specific use 
is subject to this section. The provisions of § 721.1725(b)(1) apply to paragraph (a)(2)(i) of this section. 
* * * * * 
§ 721.11514 Organic sulfonate compound 
(generic). 
(a) Chemical substance and 
significant new uses subject to reporting. 
(1) The chemical substance identified generically as organic sulfonate compound (PMN P–16–539) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. The requirements of this section do not apply to quantities of the substance after they have been completely reacted or adhered (during the photolithographic process) onto a semiconductor wafer surface or similar manufactured article used in the production of semiconductor technologies. (2) The significant new uses are: 
(i) Protection in the workplace. 
Requirements as specified in 
§ 721.63(a)(1), (a)(2)(i) and (iii), (a)(3), and (c). When determining which persons are reasonably likely to be exposed as required for § 721.63(a)(1), engineering control measures (e.g., enclosure or confinement of the operation, general and local ventilation) or administrative control measures (e.g., workplace policies and procedures) shall be considered and implemented to prevent exposure, where feasible. 
(ii) Hazard communication. 
Requirements as specified in § 721.72(a) through (e), (g)(1), (g)(2)(i) through (iii) and (v), (g)(3)(i) and (ii), and (g)(5). For purposes of § 721.72(e), the concentration is set at 1.0%. For purposes of § 721.72(g)(1), this substance may cause: Skin irritation; acute toxicity; skin sensitization; serious eye damage; specific target organ toxicity; neurotoxicity; genetic toxicity; reproductive toxicity. Alternative hazard and warning statements that meet the criteria of the Globally Harmonized System and OSHA Hazard Communication Standard may be used. 
(iii) Industrial, commercial, and 
consumer activities. Requirements as specified in § 721.80(f), (k), and (t). It is a significant new use to import the substance in any physical state other than in solution, unless in sealed containers weighing 5 kilograms or less. It is a significant new use to process the substance in any way that generates a dust, mist, or aerosol in a non-enclosed process. It is a significant new use to manufacture the substance longer than 18 months. 
(b) Specific requirements. The 
provisions of subpart A of this part apply to this section except as modified by this paragraph (b). 
(1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125(a) through (i) are applicable to manufacturers and processors of this substance. 
(2) Limitation or revocation of certain 
notification requirements. The provisions of § 721.185 apply to this section. 
(3) Determining whether a specific use 
is subject to this section. The provisions of § 721.1725(b)(1) apply to paragraph (a)(2)(iii) of this section. 
§ 721.11515 Thiophenium, 1-(2,7- 
disubstituted-1-naphthalenyl)tetrahydro-, salt with polyfluoro-N- polyfluoroalkylsulfonyl-1- alkanesulfonamide (1:1) (generic). 
(a) Chemical substance and 
significant new uses subject to reporting. 
(1) The chemical substance identified generically as thiophenium, 1-(2,7- 
disubstituted-1- naphthalenyl)tetrahydro-, salt with polyfluoro-N-polyfluoroalkylsulfonyl-1- alkanesulfonamide (1:1) (PMN P–18– 157) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. The requirements of this section do not apply to quantities of the substance after they have been completely reacted or adhered (during the photolithographic process) onto a semiconductor wafer surface or similar manufactured article used in the production of semiconductor technologies. 
(2) The significant new uses are: 
(i) Protection in the workplace. 
Requirements as specified in 
§ 721.63(a)(1), (a)(2)(i) and (iii), (a)(3), and (c). When determining which persons are reasonably likely to be exposed as required for § 721.63(a)(1), engineering control measures (e.g., enclosure or confinement of the operation, general and local ventilation) or administrative control measures (e.g., workplace policies and procedures) shall be considered and implemented to prevent exposure, where feasible. 
(ii) Hazard communication. 
Requirements as specified in § 721.72(a) through (e), (g)(1), (g)(2)(i) through (iii) and (v), (g)(3)(i) and (ii), and (g)(5). For purposes of § 721.72(e), the 
concentration is set at 1.0%. For purposes of § 721.72(g)(1), this substance may cause: Acute toxicity; skin sensitization; serious eye damage; specific target organ toxicity; neurotoxicity; genetic toxicity; reproductive toxicity. Alternative hazard and warning statements that meet the criteria of the Globally Harmonized System and OSHA Hazard Communication Standard may be used. 
(iii) Industrial, commercial, and 
consumer activities. Requirements as specified in § 721.80(f), (k), and (t). It is a significant new use to import the substance in any physical state other than in solution, unless in sealed containers weighing 5 kilograms or less. It is a significant new use to process the substance in any way that generates a dust, mist, or aerosol in a non-enclosed process. It is a significant new use to manufacture the substance longer than 18 months. 
(b) Specific requirements. The 
provisions of subpart A of this part apply to this section except as modified by this paragraph (b). 
(1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125(a) through (i) are applicable to manufacturers and processors of this substance. 
VerDate Sep<11>2014 15:55 Dec 09, 2021 Jkt 256001 PO 00000 Frm 00044 Fmt 4700 Sfmt 4700 E:\FR\FM\10DER1.SGM 10DER1jspears on DSK121TN23PROD with RULES170393 Federal Register / Vol. 86, No. 235 / Friday, December 10, 2021 / Rules and Regulations 
(2) Limitation or revocation of certain 
notification requirements. The 
provisions of § 721.185 apply to this section. 
(3) Determining whether a specific use 
is subject to this section. The provisions of § 721.1725(b)(1) apply to paragraph (a)(2)(iii) of this section. 
§ 721.11516 Sulfonium, triphenyl-, salt with 
2,3-bis(substituted) 5-sulfocarbopolycyclic- 2,3-carboxylate derivative (1:1) (generic). 
(a) Chemical substance and 
significant new uses subject to reporting. 
(1) The chemical substance identified generically as sulfonium, triphenyl-, salt with 2,3-bis(substituted) 5- sulfocarbopolycyclic-2,3-carboxylate derivative (1:1) (PMN P–18–158), is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. The requirements of this section do not apply to quantities of the substance after they have been completely reacted or adhered (during the photolithographic process) onto a semiconductor wafer surface or similar manufactured article used in the production of semiconductor technologies. 
(2) The significant new uses are: 
(i) Protection in the workplace. 
Requirements as specified in 
§ 721.63(a)(1), (a)(2)(i) and (iii), (a)(3), and (c). When determining which persons are reasonably likely to be exposed as required for § 721.63(a)(1), engineering control measures (e.g., enclosure or confinement of the operation, general and local ventilation) or administrative control measures (e.g., workplace policies and procedures) shall be considered and implemented to prevent exposure, where feasible. 
(ii) Hazard communication. 
Requirements as specified in § 721.72(a) through (e), (g)(1), (g)(2)(i) through (iii) and (v), (g)(3)(i), and (ii), and (g)(5). For purposes of § 721.72(e), the concentration is set at 1.0%. For purposes of § 721.72(g)(1), this substance may cause: Acute toxicity; skin sensitization, serious eye damage; specific target organ toxicity; neurotoxicity; genetic toxicity; reproductive toxicity. Alternative hazard and warning statements that meet the criteria of the Globally Harmonized System and OSHA Hazard Communication Standard may be used. 
(iii) Industrial, commercial, and 
consumer activities. Requirements as specified in § 721.80(f), (k), and (t). It is a significant new use to import the substance in any physical state other than in solution, unless in sealed containers weighing 5 kilograms or less. It is a significant new use to process the substance in any way that generates a dust, mist, or aerosol in a non-enclosed process. It is a significant new use to manufacture the substance longer than 18 months. 
(b) Specific requirements. The 
provisions of subpart A of this part apply to this section except as modified by this paragraph (b). 
(1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125(a) through (i) are applicable to manufacturers and processors of this substance. 
(2) Limitation or revocation of certain 
notification requirements. The provisions of § 721.185 apply to this section. 
(3) Determining whether a specific use 
is subject to this section. The provisions of § 721.1725(b)(1) apply to paragraph (a)(2)(iii) of this section. 
§ 721.11517 Thiophenium, 1-(2,7- 
disubstituted-1-naphthalenyl)tetrahydro-, salt with polyfluoro-N- polyfluoroalkylsulfonyl-1- alkanesulfonamide (1:1) (generic). 
(a) Chemical substance and 
significant new uses subject to reporting. 
(1) The chemical substance identified generically as thiophenium, 1-(2,7- disubstituted-1- naphthalenyl)tetrahydro-, salt with polyfluoro-N-polyfluoroalkylsulfonyl-1- alkanesulfonamide (1:1) (PMN P–18– 159) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. The requirements of this section do not apply to quantities of the substance after they have been completely reacted or adhered (during the photolithographic process) onto a semiconductor wafer surface or similar manufactured article used in the production of semiconductor technologies. 
(2) The significant new uses are: 
(i) Protection in the workplace. 
Requirements as specified in 
§ 721.63(a)(1), (a)(2)(i) and (iii), (a)(3), and (c). When determining which persons are reasonably likely to be exposed as required for § 721.63(a)(1) engineering control measures (e.g., enclosure or confinement of the operation, general and local ventilation) or administrative control measures (e.g., workplace policies and procedures) shall be considered and implemented to prevent exposure, where feasible. 
(ii) Hazard communication. 
Requirements as specified in § 721.72(a) through (e), (g)(1), (g)(2)(i) through (iii) and (v), (g)(3)(i) and (ii), and (g)(5). For purposes of § 721.72(e), the concentration is set at 1.0%. For purposes of § 721.72(g)(1), this substance may cause: Acute toxicity; skin sensitization; serious eye damage; specific target organ toxicity; neurotoxicity; genetic toxicity; reproductive toxicity. Alternative hazard and warning statements that meet the criteria of the Globally Harmonized System and OSHA Hazard Communication Standard may be used. 
(iii) Industrial, commercial, and 
consumer activities. Requirements as specified in § 721.80(f), (k), and (t). It is a significant new use to import the substance in any physical state other than in solution, unless in sealed containers weighing 5 kilograms or less. It is a significant new use to process the substance in any way that generates a dust, mist, or aerosol in a non-enclosed process. It is a significant new use to manufacture the substance longer than 18 months. 
(b) Specific requirements. The 
provisions of subpart A of this part apply to this section except as modified by this paragraph (b). 
(1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125(a) through (i) are applicable to manufacturers and processors of this substance. 
(2) Limitation or revocation of certain 
notification requirements. The provisions of § 721.185 apply to this section. 
(3) Determining whether a specific use 
is subject to this section. The provisions of § 721.1725(b)(1) apply to paragraph (a)(2)(iii) of this section. 
§ 721.11518 Sulfonium, triphenyl-, 5-(alkyl) 
fluoropentane derivative (generic). 
(a) Chemical substance and 
significant new uses subject to reporting. 
(1) The chemical substance identified generically as sulfonium, triphenyl-, 5- (alkyl) fluoropentane derivative (PMN P–19–33) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. The requirements of this section do not apply to quantities of the substance after they have been completely reacted or adhered (during the photolithographic process) onto a semiconductor wafer surface or similar manufactured article used in the production of semiconductor technologies. 
(2) The significant new uses are: 
(i) Protection in the workplace. 
Requirements as specified in 
§ 721.63(a)(1), (a)(2)(i) and (iii), (a)(3), and (c). When determining which persons are reasonably likely to be exposed as required for § 721.63(a)(1) engineering control measures (e.g., enclosure or confinement of the operation, general and local ventilation) or administrative control measures (e.g., 
VerDate Sep<11>2014 15:55 Dec 09, 2021 Jkt 256001 PO 00000 Frm 00045 Fmt 4700 Sfmt 4700 E:\FR\FM\10DER1.SGM 10DER1jspears on DSK121TN23PROD with RULES170394 Federal Register / Vol. 86, No. 235 / Friday, December 10, 2021 / Rules and Regulations 
workplace policies and procedures) 
shall be considered and implemented to prevent exposure, where feasible. 
(ii) Hazard communication. 
Requirements as specified in § 721.72(a) through (e), (g)(1), (a)(2)(i) through (iii) and (v), (a)(3)(i) and (ii), and (a)(5). For purposes of § 721.72(e), the concentration is set at 1.0%. For purposes of § 721.72(g)(1), this substance may cause: Acute toxicity; skin sensitization; serious eye damage; specific target organ toxicity; neurotoxicity; genetic toxicity; reproductive toxicity. Alternative hazard and warning statements that meet the criteria of the Globally Harmonized System and OSHA Hazard Communication Standard may be used. 
(iii) Industrial, commercial, and 
consumer activities. Requirements as specified in § 721.80(f), (k), and (t). It is a significant new use to import the substance in any physical state other than in solution, unless in sealed containers weighing 5 kilograms or less. It is a significant new use to process the substance in any way that generates a dust, mist, or aerosol in a non-enclosed process. It is a significant new use to manufacture the substance longer than 18 months. 
(b) Specific requirements. The 
provisions of subpart A of this part apply to this section except as modified by this paragraph (b). 
(1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125(a) through (i) are applicable to manufacturers and processors of this substance. 
(2) Limitation or revocation of certain 
notification requirements. The provisions of § 721.185 apply to this section. 
(3) Determining whether a specific use 
is subject to this section. The provisions of § 721.1725(b)(1) apply to paragraph (a)(2)(iii) of this section. 
§ 721.11519 Sulfonium, triphenyl-, salt with 
substituted-alkyl 4-substituted-benzoate (generic). 
(a) Chemical substance and 
significant new uses subject to reporting. 
(1) The chemical substance identified generically as sulfonium, triphenyl-, salt with substituted-alkyl 4-substituted- benzoate (PMN P–17–178) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. The requirements of this section do not apply to quantities of the substance after they have been completely reacted or adhered (during the photolithographic process) onto a semiconductor wafer surface or similar manufactured article used in the production of semiconductor technologies. 
(2) The significant new uses are: 
(i) Protection in the workplace. 
Requirements as specified in 
§ 721.63(a)(1), (a)(2)(i) and (iii), (a)(3), and (c). When determining which persons are reasonably likely to be exposed as required for § 721.63(a)(1) engineering control measures (e.g., enclosure or confinement of the operation, general and local ventilation) or administrative control measures (e.g., workplace policies and procedures) shall be considered and implemented to prevent exposure, where feasible. 
(ii) Hazard communication. 
Requirements as specified in § 721.72(a) through (e), (g)(1), (g)(2)(i) through (iii) and (v), (g)(3)(i) and (ii), and (g)(5). For purposes of § 721.72(e), the concentration is set at 1.0%. For purposes of § 721.72(g)(1), this substance may cause: Acute toxicity; skin sensitization; serious eye damage; specific target organ toxicity; neurotoxicity; genetic toxicity; reproductive toxicity. Alternative hazard and warning statements that meet the criteria of the Globally Harmonized System and OSHA Hazard Communication Standard may be used. 
(iii) Industrial, commercial, and 
consumer activities. Requirements as specified in § 721.80(f), (k), and (t). It is a significant new use to import the substance in any physical state other than in solution, unless in sealed containers weighing 5 kilograms or less. It is a significant new use to process the substance in any way that generates a dust, mist, or aerosol in a non-enclosed process. It is a significant new use to manufacture the substance longer than 18 months. 
(b) Specific requirements. The 
provisions of subpart A of this part apply to this section except as modified by this paragraph (b). 
(1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125(a) through (i) are applicable to manufacturers and processors of this substance. 
(2) Limitation or revocation of certain 
notification requirements. The provisions of § 721.185 apply to this section. 
(3) Determining whether a specific use 
is subject to this section. The provisions of § 721.1725(b)(1) apply to paragraph (a)(2)(iii) of this section. 
§ 721.11520 Substituted- 
triphenylsulfonium, inner salt (generic). 
(a) Chemical substance and 
significant new uses subject to reporting. 
(1) The chemical substance identified generically as substituted- triphenylsulfonium, inner salt (PMN P– 
18–13) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. The requirements of this section do not apply to quantities of the substance after they have been completely reacted or adhered (during the photolithographic process) onto a semiconductor wafer surface or similar manufactured article used in the production of semiconductor technologies. 
(2) The significant new uses are: 
(i) Protection in the workplace. 
Requirements as specified in 
§ 721.63(a)(1), (a)(2)(i) and (iii), (a)(3), and (c). When determining which persons are reasonably likely to be exposed as required for § 721.63(a)(1) engineering control measures (e.g., enclosure or confinement of the operation, general and local ventilation) or administrative control measures (e.g., workplace policies and procedures) shall be considered and implemented to prevent exposure, where feasible. 
(ii) Hazard communication. 
Requirements as specified in § 721.72(a) 
through (e), (g)(1), (g)(2)(i) through (iii) and (v), (g)(3)(i) and (ii), and (g)(5). For purposes of § 721.72(e), the concentration is set at 1.0%. For purposes of § 721.72(g)(1), this substance may cause: Acute toxicity; skin sensitization; serious eye damage; specific target organ toxicity; neurotoxicity; genetic toxicity; reproductive toxicity. Alternative hazard and warning statements that meet the criteria of the Globally Harmonized System and OSHA Hazard Communication Standard may be used. 
(iii) Industrial, commercial, and 
consumer activities. Requirements as specified in § 721.80(f), (k), and (t). It is a significant new use to import the substance in any physical state other than in solution, unless in sealed containers weighing 5 kilograms or less. It is a significant new use to process the substance in any way that generates a dust, mist, or aerosol in a non-enclosed process. It is a significant new use to manufacture the substance longer than 18 months. 
(b) Specific requirements. The 
provisions of subpart A of this part apply to this section except as modified by this paragraph (b). 
(1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125(a) through (i) are applicable to manufacturers and processors of this substance. 
(2) Limitation or revocation of certain 
notification requirements. The provisions of § 721.185 apply to this section. 
VerDate Sep<11>2014 15:55 Dec 09, 2021 Jkt 256001 PO 00000 Frm 00046 Fmt 4700 Sfmt 4700 E:\FR\FM\10DER1.SGM 10DER1jspears on DSK121TN23PROD with RULES170395 Federal Register / Vol. 86, No. 235 / Friday, December 10, 2021 / Rules and Regulations 
(3) Determining whether a specific use 
is subject to this section. The provisions 
of § 721.1725(b)(1) apply to paragraph (a)(2)(iii) of this section. 
§ 721.11521 Sulfonium, triphenyl-, salt with 
disubstituted-heterocyclic compound (1:1) (generic). 
(a) Chemical substance and 
significant new uses subject to reporting. 
(1) The chemical substance identified generically as sulfonium, triphenyl-, salt with disubstituted-heterocyclic compound (1:1) (PMN P–18–14) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. The requirements of this section do not apply to quantities of the substance after they have been completely reacted or adhered (during the photolithographic process) onto a semiconductor wafer surface or similar manufactured article used in the production of semiconductor technologies. 
(2) The significant new uses are: 
(i) Protection in the workplace. 
Requirements as specified in 
§ 721.63(a)(1), (a)(2)(i) and (iii), (a)(3), and (c). When determining which persons are reasonably likely to be exposed as required for § 721.63(a)(1), engineering control measures (e.g., enclosure or confinement of the operation, general and local ventilation) or administrative control measures (e.g., workplace policies and procedures) shall be considered and implemented to prevent exposure, where feasible. 
(ii) Hazard communication. 
Requirements as specified in § 721.72(a) through (e), (g)(1), (g)(2)(i) through (iii) and (v), (g)(3)(i) and (ii), and (g)(5). For purposes of § 721.72(e), the concentration is set at 1.0%. For purposes of § 721.72(g)(1), this substance may cause: Acute toxicity; skin sensitization; serious eye damage; specific target organ toxicity; neurotoxicity; genetic toxicity; reproductive toxicity. Alternative hazard and warning statements that meet the criteria of the Globally Harmonized System and OSHA Hazard Communication Standard may be used. 
(iii) Industrial, commercial, and 
consumer activities. Requirements as specified in § 721.80(f), (k), and (t). It is a significant new use to import the substance in any physical state other than in solution, unless in sealed containers weighing 5 kilograms or less. It is a significant new use to process the substance in any way that generates a dust, mist, or aerosol in a non-enclosed process. It is a significant new use to manufacture the substance longer than 18 months. (b) Specific requirements. The 
provisions of subpart A of this part apply to this section except as modified by this paragraph (b). 
(1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125(a) through (i) are applicable to manufacturers and processors of this substance. 
(2) Limitation or revocation of certain 
notification requirements. The provisions of § 721.185 apply to this section. 
(3) Determining whether a specific use 
is subject to this section. The provisions of § 721.1725(b)(1) apply to paragraph (a)(2)(iii) of this section. 
§ 721.11522 Sulfonium, triphenyl-, salt with 
2,4,5-trisubstituted-benzenesulfonate (1:1) (generic). 
(a) Chemical substance and 
significant new uses subject to reporting. 
(1) The chemical substance identified generically as sulfonium, triphenyl-, salt with 2,4,5-trisubstituted- benzenesulfonate (1:1) (PMN P–18–37) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. The requirements of this section do not apply to quantities of the substance after they have been completely reacted or adhered (during the photolithographic process) onto a semiconductor wafer surface or similar manufactured article used in the production of semiconductor technologies. 
(2) The significant new uses are: 
(i) Protection in the workplace. 
Requirements as specified in 
§ 721.63(a)(1), (a)(2)(i) and (iii), (a)(3), and (c). When determining which persons are reasonably likely to be exposed as required for § 721.63(a)(1), engineering control measures (e.g., enclosure or confinement of the operation, general and local ventilation) or administrative control measures (e.g., workplace policies and procedures) shall be considered and implemented to prevent exposure, where feasible. 
(ii) Hazard communication. 
Requirements as specified in § 721.72(a) through (e), (g)(1), (g)(2)(i) through (iii) and (v), (g)(3)(i) and (ii), and (g)(5). For purposes of § 721.72(e), the concentration is set at 1.0%. For purposes of § 721.72(g)(1), this substance may cause: Acute toxicity; skin sensitization; serious eye damage; specific target organ toxicity; neurotoxicity; genetic toxicity; reproductive toxicity. Alternative hazard and warning statements that meet the criteria of the Globally Harmonized System and OSHA Hazard Communication Standard may be used. (iii) Industrial, commercial, and 
consumer activities. Requirements as specified in § 721.80(f), (k), and (t). It is a significant new use to import the substance in any physical state other than in solution, unless in sealed containers weighing 5 kilograms or less. It is a significant new use to process the substance in any way that generates a dust, mist, or aerosol in a non-enclosed process. It is a significant new use to manufacture the substance longer than 18 months. 
(b) Specific requirements. The 
provisions of subpart A of this part apply to this section except as modified by this paragraph (b). 
(1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125(a) through (i) are applicable to manufacturers and processors of this substance. 
(2) Limitation or revocation of certain 
notification requirements. The provisions of § 721.185 apply to this section. 
(3) Determining whether a specific use 
is subject to this section. The provisions of § 721.1725(b)(1) apply to paragraph (a)(2)(iii) of this section. 
§ 721.11523 Substituted heterocyclic 
onium compound, salt with 2,2,2-trifluoro-1- (sulfomethyl)-1-(trifluoromethyl)ethyl 3-[(2- methyl-1-oxo-2-propen-1- yl)oxy]tricyclo[3.3.1.13,7]decane-1- carboxylate (1:1), polymer with acenaphthylene, 1-ethenyl-4-[(1- ethylcyclopentyl)oxy]benzene and 4- ethenylphenol, di-Me 2,2′-(1,2- diazenediyl)bis[2-methylpropanoate]- initiated (generic). 
(a) Chemical substance and 
significant new uses subject to reporting. 
(1) The chemical substance identified generically as substituted heterocyclic onium compound, salt with 2,2,2- trifluoro-1-(sulfomethyl)-1- (trifluoromethyl)ethyl 3-[(2-methyl-1- oxo-2-propen-1- yl)oxy]tricyclo[3.3.1.13,7]decane-1- carboxylate (1:1), polymer with acenaphthylene, 1-ethenyl-4-[(1- ethylcyclopentyl)oxy]benzene and 4- ethenylphenol, di-Me 2,2′-(1,2- diazenediyl)bis[2-methylpropanoate]- initiated (PMN P–19–78) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. The requirements of this section do not apply to quantities of the substance after they have been completely reacted or adhered (during the photolithographic process) onto a semiconductor wafer surface or similar manufactured article used in the production of semiconductor technologies. 
(2) The significant new uses are: 
VerDate Sep<11>2014 15:55 Dec 09, 2021 Jkt 256001 PO 00000 Frm 00047 Fmt 4700 Sfmt 4700 E:\FR\FM\10DER1.SGM 10DER1jspears on DSK121TN23PROD with RULES170396 Federal Register / Vol. 86, No. 235 / Friday, December 10, 2021 / Rules and Regulations 
(i) Protection in the workplace. 
Requirements as specified in 
§ 721.63(a)(1), (a)(2)(i) and (iii), (a)(3), and (c). When determining which persons are reasonably likely to be exposed as required for § 721.63(a)(1), engineering control measures (e.g., enclosure or confinement of the operation, general and local ventilation) or administrative control measures (e.g., workplace policies and procedures) shall be considered and implemented to prevent exposure, where feasible. 
(ii) Hazard communication. 
Requirements as specified in § 721.72(a) through (e), (g)(1), (g)(2)(i) through (iii) and (v), (g)(3)(i) and (ii), and (g)(5). For purposes of § 721.72(e), the concentration is set at 1.0%. For purposes of § 721.72(g)(1), this substance may cause: Acute toxicity; skin sensitization; serious eye damage; specific target organ toxicity; neurotoxicity; genetic toxicity; reproductive toxicity. Alternative hazard and warning statements that meet the criteria of the Globally Harmonized System and OSHA Hazard Communication Standard may be used. 
(iii) Industrial, commercial, and 
consumer activities. Requirements as specified in § 721.80(f), (k), and (t). It is a significant new use to import the substance in any physical state other than in solution, unless in sealed containers weighing 5 kilograms or less. It is a significant new use to process the substance in any way that generates a dust, mist, or aerosol in a non-enclosed process. It is a significant new use to manufacture the substance longer than 18 months. 
(b) Specific requirements. The 
provisions of subpart A of this part apply to this section except as modified by this paragraph (b). 
(1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125(a) through (i) are applicable to manufacturers and processors of this substance. 
(2) Limitation or revocation of certain 
notification requirements. The provisions of § 721.185 apply to this section. 
(3) Determining whether a specific use 
is subject to this section. The provisions of § 721.1725(b)(1) apply to paragraph (a)(2)(iii) of this section. § 721.11524 Substituted heterocyclic 
onium compound, salt with 2,2,2-trifluoro-1- (sulfomethyl)-1-(trifluoromethyl)ethyl 3-[(2- methyl-1-oxo-2-propen-1- yl)oxy]tricyclo[3.3.1.13,7]decane-1- carboxylate (1:1), polymer with acenaphthylene, 1-ethenyl-4-[[1-(1- methylethyl)cyclopentyl]oxy]benzene and 4- ethenylphenol, di-Me 2,2′-(1,2- diazenediyl)bis[2-methylpropanoate]- initiated (generic). 
(a) Chemical substance and 
significant new uses subject to reporting. 
(1) The chemical substance identified generically as substituted heterocyclic onium compound, salt with 2,2,2- trifluoro-1-(sulfomethyl)-1- (trifluoromethyl)ethyl 3-[(2-methyl-1- oxo-2-propen-1- yl)oxy]tricyclo[3.3.1.13,7]decane-1- carboxylate (1:1), polymer with acenaphthylene, 1-ethenyl-4-[[1-(1- methylethyl)cyclopentyl]oxy]benzene and 4-ethenylphenol, di-Me 2,2′-(1,2- diazenediyl)bis[2-methylpropanoate]- initiated (PMN P–19–79) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. The requirements of this section do not apply to quantities of the substance after they have been completely reacted or adhered (during the photolithographic process) onto a semiconductor wafer surface or similar manufactured article used in the production of semiconductor technologies. 
(2) The significant new uses are: 
(i) Protection in the workplace. 
Requirements as specified in 
§ 721.63(a)(1), (a)(2)(i) and (iii), (a)(3), and (c). When determining which persons are reasonably likely to be exposed as required for § 721.63(a)(1), engineering control measures (e.g., enclosure or confinement of the operation, general and local ventilation) or administrative control measures (e.g., workplace policies and procedures) shall be considered and implemented to prevent exposure, where feasible. 
(ii) Hazard communication. 
Requirements as specified in § 721.72(a) through (e), (g)(1), (g)(2)(i) through (iii) and (v), (g)(3)(i) and (ii), and (g)(5). For 
purposes of § 721.72(e), the concentration is set at 1.0%. For purposes of § 721.72(g)(1), this substance may cause: Acute toxicity; skin sensitization; serious eye damage; specific target organ toxicity; neurotoxicity; genetic toxicity; reproductive toxicity. Alternative hazard and warning statements that meet the criteria of the Globally Harmonized System and OSHA Hazard Communication Standard may be used. 
(iii) Industrial, commercial, and 
consumer activities. Requirements as specified in § 721.80(f), (k), and (t). It is a significant new use to import the substance in any physical state other than in solution, unless in sealed containers weighing 5 kilograms or less. It is a significant new use to process the substance in any way that generates a dust, mist, or aerosol in a non-enclosed process. It is a significant new use to manufacture the substance longer than 18 months. 
(b) Specific requirements. The 
provisions of subpart A of this part apply to this section except as modified by this paragraph (b). 
(1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125(a) through (i) are applicable to manufacturers and processors of this substance. 
(2) Limitation or revocation of certain 
notification requirements. The provisions of § 721.185 apply to this section. 
(3) Determining whether a specific use 
is subject to this section. The provisions of § 721.1725(b)(1) apply to paragraph (a)(2)(iii) of this section. 
§ 721.11525 Dibenzothiophenium, aryl 
substituted trifluoro-hydroxy- (triheterosubstitutedalkyl)alkanoate (1:1) (generic). 
(a) Chemical substance and 
significant new uses subject to reporting. 
(1) The chemical substance identified generically as dibenzothiophenium, aryl substituted trifluoro-hydroxy- (triheterosubstitutedalkyl)alkanoate (1:1) (PMN P–19–111) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. The requirements of this section do not apply to quantities of the substance after they have been completely reacted or adhered (during the photolithographic process) onto a semiconductor wafer surface or similar manufactured article used in the production of semiconductor technologies. 
(2) The significant new uses are: 
(i) Protection in the workplace. 
Requirements as specified in 
§ 721.63(a)(1), (a)(2)(i) and (iii), (a)(3), and (c). When determining which persons are reasonably likely to be exposed as required for § 721.63(a)(1), engineering control measures (e.g., enclosure or confinement of the operation, general and local ventilation) or administrative control measures (e.g., workplace policies and procedures) shall be considered and implemented to prevent exposure, where feasible. 
(ii) Hazard communication. 
Requirements as specified in § 721.72(a) through (e), (g)(1), (g)(2)(i) through (iii) and (v), (g)(3)(i) and (ii), and (g)(5). For purposes of § 721.72(e), the 
VerDate Sep<11>2014 15:55 Dec 09, 2021 Jkt 256001 PO 00000 Frm 00048 Fmt 4700 Sfmt 4700 E:\FR\FM\10DER1.SGM 10DER1jspears on DSK121TN23PROD with RULES170397 Federal Register / Vol. 86, No. 235 / Friday, December 10, 2021 / Rules and Regulations 
concentration is set at 1.0%. For 
purposes of § 721.72(g)(1), this substance may cause: Acute toxicity; skin sensitization; serious eye damage; specific target organ toxicity; neurotoxicity; genetic toxicity; reproductive toxicity. Alternative hazard and warning statements that meet the criteria of the Globally Harmonized System and OSHA Hazard Communication Standard may be used. 
(iii) Industrial, commercial, and 
consumer activities. Requirements as specified in § 721.80(f), (k), and (t). It is a significant new use to import the substance in any physical state other than in solution, unless in sealed containers weighing 5 kilograms or less. It is a significant new use to process the substance in any way that generates a dust, mist, or aerosol in a non-enclosed process. It is a significant new use to manufacture the substance longer than 18 months. 
(b) Specific requirements. The 
provisions of subpart A of this part apply to this section except as modified by this paragraph (b). 
(1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125(a) through (i) are applicable to manufacturers and processors of this substance. 
(2) Limitation or revocation of certain 
notification requirements. The provisions of § 721.185 apply to this section. 
(3) Determining whether a specific use 
is subject to this section. The provisions of § 721.1725(b)(1) apply to paragraph (a)(2)(iii) of this section. 
§ 721.11526 Substituted heterocyclic 
onium compound, salt with 1- (difluorosulfomethyl)-2,2,2-trifluoroethyl 3- [(2-methyl-1-oxo-2-propen-1- yl)oxy]tricyclo[3.3.1.13,7]decane-1- carboxylate (1:1), polymer with 3- ethenylphenol, 1-(1-methylethyl)cyclopentyl 2-methyl-2-propenoate and 1-(7- oxabicyclo[2.2.1]hept-2-yl)cyclopentyl 2- methyl-2-propenoate, di-Me 2,2′-(1,2- diazenediyl)bis[2-methylpropenoate]- initiated (generic). 
(a) Chemical substance and 
significant new uses subject to reporting. 
(1) The chemical substance identified generically as substituted heterocyclic onium compound, salt with 1- (difluorosulfomethyl)-2,2,2- trifluoroethyl 3-[(2-methyl-1-oxo-2- propen-1- yl)oxy]tricyclo[3.3.1.13,7]decane-1- carboxylate (1:1), polymer with 3- ethenylphenol, 1-(1- methylethyl)cyclopentyl 2-methyl-2- propenoate and 1-(7- oxabicyclo[2.2.1]hept-2-yl)cyclopentyl 2-methyl-2-propenoate, di-Me 2,2′-(1,2- diazenediyl)bis[2-methylpropenoate]- initiated (PMN P–19–112) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. The requirements of this section do not apply to quantities of the substance after they have been completely reacted or adhered (during the photolithographic process) onto a semiconductor wafer surface or similar manufactured article used in the production of semiconductor technologies. 
(2) The significant new uses are: 
(i) Protection in the workplace. 
Requirements as specified in 
§ 721.63(a)(1), (a)(2)(i) and (iii), (a)(3), and (c). When determining which persons are reasonably likely to be exposed as required for § 721.63(a)(1), engineering control measures (e.g., enclosure or confinement of the operation, general and local ventilation) or administrative control measures (e.g., workplace policies and procedures) shall be considered and implemented to prevent exposure, where feasible. 
(ii) Hazard communication. 
Requirements as specified in § 721.72(a) through (e), (g)(1), (g)(2)(i) through (iii) and (v), (g)(3)(i) and (ii), and (g)(5). For purposes of § 721.72(e), the concentration is set at 1.0%. For purposes of § 721.72(g)(1), this substance may cause: Acute toxicity; skin sensitization; serious eye damage; specific target organ toxicity; neurotoxicity; genetic toxicity; reproductive toxicity. Alternative hazard and warning statements that meet the criteria of the Globally Harmonized System and OSHA Hazard Communication Standard may be used. 
(iii) Industrial, commercial, and 
consumer activities. Requirements as specified in § 721.80(f), (k), and (t). It is a significant new use to import the substance in any physical state other than in solution, unless in sealed containers weighing 5 kilograms or less. It is a significant new use to process the substance in any way that generates a dust, mist, or aerosol in a non-enclosed process. It is a significant new use to manufacture the substance longer than 18 months. 
(b) Specific requirements. The 
provisions of subpart A of this part apply to this section except as modified by this paragraph (b). 
(1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125(a) through (i) are applicable to manufacturers and processors of this substance. 
(2) Limitation or revocation of certain 
notification requirements. The provisions of § 721.185 apply to this section. (3) Determining whether a specific use 
is subject to this section. The provisions of § 721.1725(b)(1) apply to paragraph (a)(2)(iii) of this section. 
§ 721.11527 Sulfonium, triphenyl-, 
trifluoro-hydroxy- (triheterosubstitutedalkyl)alkanoate (1:1) (generic). 
(a) Chemical substance and 
significant new uses subject to reporting. 
(1) The chemical substance identified generically as sulfonium, triphenyl-, trifluoro-hydroxy- (triheterosubstitutedalkyl)alkanoate (1:1) (PMN P–19–114) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. The requirements of this section do not apply to quantities of the substance after they have been completely reacted or adhered (during the photolithographic process) onto a semiconductor wafer surface or similar manufactured article used in the production of semiconductor technologies. 
(2) The significant new uses are: 
(i) Protection in the workplace. 
Requirements as specified in 
§ 721.63(a)(1), (a)(2)(i) and (iii), (a)(3), and (c). When determining which persons are reasonably likely to be exposed as required for § 721.63(a)(1), engineering control measures (e.g., enclosure or confinement of the operation, general and local ventilation) or administrative control measures (e.g., workplace policies and procedures) shall be considered and implemented to prevent exposure, where feasible. 
(ii) Hazard communication. 
Requirements as specified in § 721.72(a) through (e), (g)(1), (g)(2)(i) through (iii) and (v), (g)(3)(i) and (ii), and (g)(5). For purposes of § 721.72(e), the concentration is set at 1.0%. For purposes of § 721.72(g)(1), this substance may cause: Acute toxicity; skin sensitization; serious eye damage; specific target organ toxicity; neurotoxicity; genetic toxicity; reproductive toxicity. Alternative hazard and warning statements that meet the criteria of the Globally Harmonized System and OSHA Hazard Communication Standard may be used. 
(iii) Industrial, commercial, and 
consumer activities. Requirements as specified in § 721.80(f), (k), and (t). It is a significant new use to import the substance in any physical state other than in solution, unless in sealed containers weighing 5 kilograms or less. It is a significant new use to process the substance in any way that generates a dust, mist, or aerosol in a non-enclosed process. It is a significant new use to 
VerDate Sep<11>2014 15:55 Dec 09, 2021 Jkt 256001 PO 00000 Frm 00049 Fmt 4700 Sfmt 4700 E:\FR\FM\10DER1.SGM 10DER1jspears on DSK121TN23PROD with RULES170398 Federal Register / Vol. 86, No. 235 / Friday, December 10, 2021 / Rules and Regulations 
manufacture the substance longer than 
18 months. 
(b) Specific requirements. The 
provisions of subpart A of this part apply to this section except as modified by this paragraph (b). 
(1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125(a) through (i) are applicable to manufacturers and processors of this substance. 
(2) Limitation or revocation of certain 
notification requirements. The provisions of § 721.185 apply to this section. 
(3) Determining whether a specific use 
is subject to this section. The provisions of § 721.1725(b)(1) apply to paragraph (a)(2)(iii) of this section. 
§ 721.11528 Heterotrisubstituted-bile acid, 
1-(difluorosulfomethyl)-2,2,2-trifluoroethyl ester, ion(1-), (5)-, triphenylsulfonium (1:1) (generic). 
(a) Chemical substance and 
significant new uses subject to reporting. 
(1) The chemical substance identified generically as heterotrisubstituted-bile acid, 1-(difluorosulfomethyl)-2,2,2- trifluoroethyl ester, ion(1-), (5)-, triphenylsulfonium (1:1) (PMN P–19– 133) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. The requirements of this section do not apply to quantities of the substance after they have been completely reacted or adhered (during the photolithographic process) onto a semiconductor wafer surface or similar manufactured article used in the production of semiconductor technologies. 
(2) The significant new uses are: 
(i) Protection in the workplace. 
Requirements as specified in 
§ 721.63(a)(1), (a)(2)(i) and (iii), (a)(3), and (c). When determining which persons are reasonably likely to be exposed as required for § 721.63(a)(1), engineering control measures (e.g., enclosure or confinement of the operation, general and local ventilation) or administrative control measures (e.g., workplace policies and procedures) shall be considered and implemented to prevent exposure, where feasible. 
(ii) Hazard communication. 
Requirements as specified in § 721.72(a) through (e), (g)(1), (g)(2)(i) through (iii) and (v), (g)(3)(i) and (ii), and (g)(5). For purposes of § 721.72(e), the concentration is set at 1.0%. For purposes of § 721.72(g)(1), this substance may cause: Acute toxicity; skin sensitization; serious eye damage; specific target organ toxicity; neurotoxicity; genetic toxicity; reproductive toxicity. (iii) Industrial, commercial, and 
consumer activities. Requirements as specified in § 721.80(f), (k), and (t). It is a significant new use to import the substance in any physical state other than in solution, unless in sealed containers weighing 5 kilograms or less. It is a significant new use to process the substance in any way that generates a dust, mist, or aerosol in a non-enclosed process. It is a significant new use to manufacture the substance longer than 18 months. 
(b) Specific requirements. The 
provisions of subpart A of this part apply to this section except as modified by this paragraph (b). 
(1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125(a) through (i) are applicable to manufacturers and processors of this substance. 
(2) Limitation or revocation of certain 
notification requirements. The provisions of § 721.185 apply to this section. 
(3) Determining whether a specific use 
is subject to this section. The provisions of § 721.1725(b)(1) apply to paragraph (a)(2)(iii) of this section. 
§ 721.11529 Aromatic sulfonium tricyclo 
fluoroalkyl sulfonic acid salt (generic). 
(a) Chemical substance and 
significant new uses subject to reporting. 
(1) The chemical substance identified generically as aromatic sulfonium tricyclo fluoroalkyl sulfonic acid salt (PMN P–18–16) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. The requirements of this section do not apply to quantities of the substance after they have been completely reacted or adhered (during the photolithographic process) onto a semiconductor wafer surface or similar manufactured article used in the production of semiconductor technologies. 
(2) The significant new uses are: 
(i) Protection in the workplace. 
Requirements as specified in 
§ 721.63(a)(1), (a)(2)(i) and (iii), (a)(3), and (c). When determining which persons are reasonably likely to be exposed as required for § 721.63(a)(1), engineering control measures (e.g., enclosure or confinement of the operation, general and local ventilation) or administrative control measures (e.g., workplace policies and procedures) shall be considered and implemented to prevent exposure, where feasible. 
(ii) Hazard communication. 
Requirements as specified in § 721.72(a) through (e), (g)(1), (g)(2)(i) through (iii) and (v), (g)(3)(i) and (ii), and (g)(5). For purposes of § 721.72(e), the concentration is set at 1.0%. For purposes of § 721.72(g)(1), this substance may cause: Acute toxicity; skin sensitization; serious eye damage; specific target organ toxicity; neurotoxicity; genetic toxicity; reproductive toxicity. Alternative hazard and warning statements that meet the criteria of the Globally Harmonized System and OSHA Hazard Communication Standard may be used. 
(iii) Industrial, commercial, and 
consumer activities. Requirements as specified in § 721.80(f), (k), and (t). It is a significant new use to import the substance in any physical state other than in solution, unless in sealed containers weighing 5 kilograms or less. It is a significant new use to use or process the substance in any way that generates a dust, mist, or aerosol in a non-enclosed process. It is a significant new use to manufacture the substance longer than 18 months. 
(b) Specific requirements. The 
provisions of subpart A of this part apply to this section except as modified by this paragraph (b). 
(1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125(a) through (i) are applicable to manufacturers and processors of this substance. 
(2) Limitation or revocation of certain 
notification requirements. The provisions of § 721.185 apply to this section. 
(3) Determining whether a specific use 
is subject to this section. The provisions of § 721.1725(b)(1) apply to paragraph (a)(2)(iii) of this section. 
§ 721.11530 Substituted, 
(alkylaromatic)diaromatic salt with trihalo- [(trihaloalkyl)substituted]substituted alkaneamide (generic). 
(a) Chemical substance and 
significant new uses subject to reporting. 
(1) The chemical substance identified generically as substituted, (alkylaromatic)diaromatic salt with trihalo- [(trihaloalkyl)substituted]substituted alkaneamide (PMN P–18–297) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. The requirements of this section do not apply to quantities of the substance after they have been completely reacted or adhered (during the photolithographic process) onto a semiconductor wafer surface or similar manufactured article used in the production of semiconductor technologies. 
(2) The significant new uses are: 
(i) Protection in the workplace. 
Requirements as specified in 
§ 721.63(a)(1), (a)(2)(i) and (iii), (a)(3), 
VerDate Sep<11>2014 15:55 Dec 09, 2021 Jkt 256001 PO 00000 Frm 00050 Fmt 4700 Sfmt 4700 E:\FR\FM\10DER1.SGM 10DER1jspears on DSK121TN23PROD with RULES170399 Federal Register / Vol. 86, No. 235 / Friday, December 10, 2021 / Rules and Regulations 
and (c). When determining which 
persons are reasonably likely to be exposed as required for § 721.63(a)(1), engineering control measures (e.g., enclosure or confinement of the operation, general and local ventilation) or administrative control measures (e.g., workplace policies and procedures) shall be considered and implemented to prevent exposure, where feasible. 
(ii) Hazard communication. 
Requirements as specified in § 721.72(a) through (e), (g)(1), (g)(2)(i) through (iii) and (v), (g)(3)(i) and (ii), and (g)(5). For purposes of § 721.72(e), the concentration is set at 1.0%. For purposes of § 721.72(g)(1), this substance may cause: Acute toxicity; skin sensitization; serious eye damage; specific target organ toxicity; neurotoxicity; genetic toxicity; reproductive toxicity. Alternative hazard and warning statements that meet the criteria of the Globally Harmonized System and OSHA Hazard Communication Standard may be used. 
(iii) Industrial, commercial, and 
consumer activities. Requirements as specified in § 721.80(f), (k), and (t). It is a significant new use to import the substance in any physical state other than in solution, unless in sealed containers weighing 5 kilograms or less. It is a significant new use to process the substance in any way that generates a dust, mist, or aerosol in a non-enclosed process. It is a significant new use to manufacture the substance longer than 18 months. 
(b) Specific requirements. The 
provisions of subpart A of this part apply to this section except as modified by this paragraph (b). 
(1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125(a) through (i) are applicable to manufacturers and processors of this substance. 
(2) Limitation or revocation of certain 
notification requirements. The provisions of § 721.185 apply to this section. 
(3) Determining whether a specific use 
is subject to this section. The provisions of § 721.1725(b)(1) apply to paragraph (a)(2)(iii) of this section. 
§ 721.11531 Triarylsulfonium substituted 
oxatricycloalkyloxycarbonyl dihalo alkane sulfonate (generic). 
(a) Chemical substance and 
significant new uses subject to reporting. 
(1) The chemical substance identified generically as triarylsulfonium substituted oxatricycloalkyloxycarbonyl dihalo alkane sulfonate (PMN P–18– 311) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. The requirements of this section 
do not apply to quantities of the substance after they have been completely reacted or adhered (during the photolithographic process) onto a semiconductor wafer surface or similar manufactured article used in the production of semiconductor technologies. 
(2) The significant new uses are: 
(i) Protection in the workplace. 
Requirements as specified in 
§ 721.63(a)(1), (a)(2)(i) and (iii), (a)(3), and (c). When determining which persons are reasonably likely to be exposed as required for § 721.63(a)(1), engineering control measures (e.g., enclosure or confinement of the operation, general and local ventilation) 
or administrative control measures (e.g., workplace policies and procedures) shall be considered and implemented to prevent exposure, where feasible. 
(ii) Hazard communication. 
Requirements as specified in § 721.72(a) through (e), (g)(1), (g)(2)(i) through (iii) and (v), (g)(3)(i) and (ii), and (g)(5). For purposes of § 721.72(e), the concentration is set at 1.0%. For purposes of § 721.72(g)(1), this substance may cause: Acute toxicity; skin sensitization; serious eye damage; specific target organ toxicity; neurotoxicity; genetic toxicity; reproductive toxicity. Alternative hazard and warning statements that meet the criteria of the Globally Harmonized System and OSHA Hazard Communication Standard may be used. 
(iii) Industrial, commercial, and 
consumer activities. Requirements as specified in § 721.80(f), (k), and (t). It is a significant new use to import the substance in any physical state other than in solution, unless in sealed containers weighing 5 kilograms or less. It is a significant new use to process the substance in any way that generates a dust, mist, or aerosol in a non-enclosed process. It is a significant new use to manufacture the substance longer than 18 months. 
(b) Specific requirements. The 
provisions of subpart A of this part apply to this section except as modified by this paragraph (b). 
(1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125(a) through (i) are applicable to manufacturers and processors of this substance. 
(2) Limitation or revocation of certain 
notification requirements. The provisions of § 721.185 apply to this section. 
(3) Determining whether a specific use 
is subject to this section. The provisions of § 721.1725(b)(1) apply to paragraph (a)(2)(iii) of this section. § 721.11532 Substituted triarylsulfonium 
carbopolycyclic heteromonocyclic dihalo sulfoacetate (generic). 
(a) Chemical substance and 
significant new uses subject to reporting. 
(1) The chemical substance identified generically as substituted triarylsulfonium carbopolycyclic heteromonocyclic dihalo sulfoacetate (PMN P–18–314) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. The requirements of this section do not apply to quantities of the substance after they have been completely reacted or adhered (during the photolithographic process) onto a semiconductor wafer surface or similar manufactured article used in the production of semiconductor technologies. 
(2) The significant new uses are: 
(i) Protection in the workplace. 
Requirements as specified in 
§ 721.63(a)(1), (a)(2)(i) and (iii), (a)(3), and (c). When determining which persons are reasonably likely to be exposed as required for § 721.63(a)(1), engineering control measures (e.g., enclosure or confinement of the operation, general and local ventilation) or administrative control measures (e.g., workplace policies and procedures) shall be considered and implemented to prevent exposure, where feasible. 
(ii) Hazard communication. 
Requirements as specified in § 721.72(a) through (e), (g)(1), (g)(2)(i) through (iii) and (v), (g)(3)(i) and (ii), and (g)(5). For purposes of § 721.72(e), the concentration is set at 1.0%. For purposes of § 721.72(g)(1), this substance may cause: Acute toxicity; skin sensitization; serious eye damage; specific target organ toxicity; neurotoxicity; genetic toxicity; reproductive toxicity. Alternative hazard and warning statements that meet the criteria of the Globally Harmonized System and OSHA Hazard Communication Standard may be used. 
(iii) Industrial, commercial, and 
consumer activities. Requirements as specified in § 721.80(f), (k), and (t). It is a significant new use to import the substance in any physical state other than in solution, unless in sealed containers weighing 5 kilograms or less. It is a significant new use to process the substance in any way that generates a dust, mist, or aerosol in a non-enclosed process. It is a significant new use to manufacture the substance longer than 18 months. 
(b) Specific requirements. The 
provisions of subpart A of this part apply to this section except as modified by this paragraph (b). 
VerDate Sep<11>2014 15:55 Dec 09, 2021 Jkt 256001 PO 00000 Frm 00051 Fmt 4700 Sfmt 4700 E:\FR\FM\10DER1.SGM 10DER1jspears on DSK121TN23PROD with RULES170400 Federal Register / Vol. 86, No. 235 / Friday, December 10, 2021 / Rules and Regulations 
(1) Recordkeeping. Recordkeeping 
requirements as specified in 
§ 721.125(a) through (i) are applicable to manufacturers and processors of this substance. 
(2) Limitation or revocation of certain 
notification requirements. The provisions of § 721.185 apply to this section. 
(3) Determining whether a specific use 
is subject to this section. The provisions of § 721.1725(b)(1) apply to paragraph (a)(2)(iii) of this section. 
§ 721.11533 Substituted triarylsulfonium 
substituted carbopolycyclic carboxylate (generic). 
(a) Chemical substance and 
significant new uses subject to reporting. 
(1) The chemical substance identified generically as substituted triarylsulfonium substituted carbopolycyclic carboxylate (PMN P– 18–315) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. The requirements of this section do not apply to quantities of the substance after they have been completely reacted or adhered (during the photolithographic process) onto a semiconductor wafer surface or similar manufactured article used in the production of semiconductor technologies. 
(2) The significant new uses are: 
(i) Protection in the workplace. 
Requirements as specified in 
§ 721.63(a)(1), (a)(2)(i) and (iii), (a)(3), and (c). When determining which persons are reasonably likely to be exposed as required for § 721.63(a)(1), engineering control measures (e.g., enclosure or confinement of the operation, general and local ventilation) or administrative control measures (e.g., workplace policies and procedures) shall be considered and implemented to prevent exposure, where feasible. 
(ii) Hazard communication. 
Requirements as specified in § 721.72(a) through (e), (g)(1), (g)(2)(i) through (iii) and (v), (g)(3)(i) and (ii), and (g)(5). For purposes of § 721.72(e), the concentration is set at 1.0%. For purposes of § 721.72(g)(1), this substance may cause: Acute toxicity; skin sensitization; serious eye damage; specific target organ toxicity; neurotoxicity; genetic toxicity; reproductive toxicity. Alternative hazard and warning statements that meet the criteria of the Globally Harmonized System and OSHA Hazard Communication Standard may be used. 
(iii) Industrial, commercial, and 
consumer activities. Requirements as specified in § 721.80(f), (k), and (t). It is a significant new use to import the substance in any physical state other than in solution, unless in sealed containers weighing 5 kilograms or less. It is a significant new use to process the substance in any way that generates a dust, mist, or aerosol in a non-enclosed process. It is a significant new use to manufacture the substance longer than 18 months. 
(b) Specific requirements. The 
provisions of subpart A of this part apply to this section except as modified by this paragraph (b). 
(1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125(a) through (i) are applicable to manufacturers and processors of this substance. 
(2) Limitation or revocation of certain 
notification requirements. The provisions of § 721.185 apply to this section. 
(3) Determining whether a specific use 
is subject to this section. The provisions of § 721.1725(b)(1) apply to paragraph (a)(2)(iii) of this section. 
§ 721.11534 Sulfonium, 
bis(dihalocarbomonocycle) carbomonocycle, salt with substituted heteropolycycle dihalo sulfoalkanoate (1:1) (generic). 
(a) Chemical substance and 
significant new uses subject to reporting. 
(1) The chemical substance identified generically as sulfonium, bis(dihalocarbomonocycle) carbomonocycle, salt with substituted heteropolycycle dihalo sulfoalkanoate (1:1) (PMN P–18–304) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. The requirements of this section do not apply to quantities of the substance after they have been completely reacted or adhered (during the photolithographic process) onto a semiconductor wafer surface or similar manufactured article used in the production of semiconductor technologies. 
(2) The significant new uses are: 
(i) Protection in the workplace. 
Requirements as specified in 
§ 721.63(a)(1), (a)(2)(i) and (iii), (a)(3), and (c). When determining which persons are reasonably likely to be exposed as required for § 721.63(a)(1), engineering control measures (e.g., enclosure or confinement of the operation, general and local ventilation) or administrative control measures (e.g., workplace policies and procedures) shall be considered and implemented to prevent exposure, where feasible. 
(ii) Hazard communication. 
Requirements as specified in § 721.72(a) through (e), (g)(1), (g)(2)(i) through (iii) and (v), (g)(3)(i) and (ii), and (g)(5). For purposes of § 721.72(e), the concentration is set at 1.0%. For purposes of § 721.72(g)(1), this substance may cause: Acute toxicity; skin sensitization; serious eye damage; specific target organ toxicity; neurotoxicity; genetic toxicity; reproductive toxicity. Alternative hazard and warning statements that meet the criteria of the Globally Harmonized System and OSHA Hazard Communication Standard may be used. 
(iii) Industrial, commercial, and 
consumer activities. Requirements as specified in § 721.80(f), (k), and (t). It is a significant new use to import the substance in any physical state other than in solution, unless in sealed containers weighing 5 kilograms or less. It is a significant new use to process the substance in any way that generates a dust, mist, or aerosol in a non-enclosed process. It is a significant new use to manufacture the substance longer than 18 months. 
(b) Specific requirements. The 
provisions of subpart A of this part apply to this section except as modified by this paragraph (b). 
(1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125(a) through (i) are applicable to manufacturers and processors of this substance. 
(2) Limitation or revocation of certain 
notification requirements. The provisions of § 721.185 apply to this section. 
(3) Determining whether a specific use 
is subject to this section. The provisions of § 721.1725(b)(1) apply to paragraph (a)(2)(iii) of this section. 
§ 721.11535 Heteropolycycle, 
alkylaromatic-, salt with dihalo-substituted alkyl carbopolycycle carboxylate (generic). 
(a) Chemical substance and 
significant new uses subject to reporting. 
(1) The chemical substance identified generically heteropolycycle, alkylaromatic-, salt with dihalo- substituted alkyl carbopolycycle carboxylate (PMN P–18–316) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. The requirements of this section do not apply to quantities of the substance after they have been completely reacted or adhered (during the photolithographic process) onto a semiconductor wafer surface or similar manufactured article used in the production of semiconductor technologies. 
(2) The significant new uses are: 
(i) Protection in the workplace. 
Requirements as specified in 
§ 721.63(a)(1), (a)(2)(i) and (iii), (a)(3), and (c). When determining which 
VerDate Sep<11>2014 15:55 Dec 09, 2021 Jkt 256001 PO 00000 Frm 00052 Fmt 4700 Sfmt 4700 E:\FR\FM\10DER1.SGM 10DER1jspears on DSK121TN23PROD with RULES170401 Federal Register / Vol. 86, No. 235 / Friday, December 10, 2021 / Rules and Regulations 
persons are reasonably likely to be 
exposed as required for § 721.63(a)(1), engineering control measures (e.g., enclosure or confinement of the operation, general and local ventilation) or administrative control measures (e.g., workplace policies and procedures) shall be considered and implemented to prevent exposure, where feasible. 
(ii) Hazard communication. 
Requirements as specified in § 721.72(a) through (e), (g)(1), (g)(2)(i) through (iii) and (v), (g)(3)(i) and (ii), and (g)(5). For purposes of § 721.72(e), the concentration is set at 1.0%. For purposes of § 721.72(g)(1), this substance may cause: Acute toxicity; skin sensitization; serious eye damage; specific target organ toxicity; neurotoxicity; genetic toxicity; reproductive toxicity. Alternative hazard and warning statements that meet the criteria of the Globally Harmonized System and OSHA Hazard Communication Standard may be used. 
(iii) Industrial, commercial, and 
consumer activities. Requirements as specified in § 721.80(f), (k), and (t). It is a significant new use to import the substance in any physical state other than in solution, unless in sealed containers weighing 5 kilograms or less. It is a significant new use to process the substance in any way that generates a dust, mist, or aerosol in a non-enclosed process. It is a significant new use to manufacture the substance longer than 18 months. 
(b) Specific requirements. The 
provisions of subpart A of this part apply to this section except as modified by this paragraph (b). 
(1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125(a) through (i) are applicable to manufacturers and processors of this substance. 
(2) Limitation or revocation of certain 
notification requirements. The provisions of § 721.185 apply to this section. 
(3) Determining whether a specific use 
is subject to this section. The provisions of § 721.1725(b)(1) apply to paragraph (a)(2)(iii) of this section. 
§ 721.11536 Sulfonium, triaryl-, salt with 
polyhalo-4-sulfoalkyl polycarbocyclic alkane-1-carboxylate (1:1) (generic). 
(a) Chemical substance and 
significant new uses subject to reporting. 
(1) The chemical substance identified generically as sulfonium, triaryl-, salt with polyhalo-4-sulfoalkyl polycarbocyclic alkane-1-carboxylate (1:1) (PMN P–18–338) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. The requirements of this section do not apply to quantities of the substance after they have been completely reacted or adhered (during the photolithographic process) onto a semiconductor wafer surface or similar manufactured article used in the production of semiconductor technologies. 
(2) The significant new uses are: 
(i) Protection in the workplace. 
Requirements as specified in 
§ 721.63(a)(1), (a)(2)(i) and (iii), (a)(3), and (c). When determining which persons are reasonably likely to be exposed as required for § 721.63(a)(1), engineering control measures (e.g., enclosure or confinement of the operation, general and local ventilation) or administrative control measures (e.g., workplace policies and procedures) shall be considered and implemented to prevent exposure, where feasible. 
(ii) Hazard communication. 
Requirements as specified in § 721.72(a) through (e), (g)(1), (g)(2)(i) through (iii) and (v), (g)(3)(i) and (ii), and (g)(5). For purposes of § 721.72(e), the concentration is set at 1.0%. For purposes of § 721.72(g)(1), this substance may cause: Acute toxicity; skin sensitization; serious eye damage; specific target organ toxicity; neurotoxicity; genetic toxicity; reproductive toxicity. Alternative hazard and warning statements that meet the criteria of the Globally Harmonized System and OSHA Hazard Communication Standard may be used. 
(iii) Industrial, commercial, and 
consumer activities. Requirements as specified in § 721.80(f), (k), and (t). It is a significant new use to import the substance in any physical state other than in solution, unless in sealed containers weighing 5 kilograms or less. It is a significant new use to process the substance in any way that generates a dust, mist, or aerosol in a non-enclosed process. It is a significant new use to manufacture the substance longer than 18 months. 
(b) Specific requirements. The 
provisions of subpart A of this part apply to this section except as modified by this paragraph (b). 
(1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125(a) through (i) are applicable to manufacturers and processors of this substance. 
(2) Limitation or revocation of certain 
notification requirements. The provisions of § 721.185 apply to this section. 
(3) Determining whether a specific use 
is subject to this section. The provisions of § 721.1725(b)(1) apply to paragraph (a)(2)(iii) of this section. § 721.11537 Sulfonium, 
bis(dihalocarbomonocycle) carbomonocycle, salt with dihalo 
substituted alkyl carbopolycyclic carboxylate (1:1) (generic). 
(a) Chemical substance and 
significant new uses subject to reporting. 
(1) The chemical substance identified generically as sulfonium, bis(dihalocarbomonocycle) carbomonocycle, salt with dihalo substituted alkyl carbopolycyclic carboxylate (1:1) (PMN P–19–76) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. The requirements of this section do not apply to quantities of the substance after they have been completely reacted or adhered (during the photolithographic process) onto a semiconductor wafer surface or similar manufactured article used in the production of semiconductor technologies. 
(2) The significant new uses are: 
(i) Protection in the workplace. 
Requirements as specified in 
§ 721.63(a)(1), (a)(2)(i) and (iii), (a)(3), and (c). When determining which persons are reasonably likely to be exposed as required for § 721.63(a)(1), engineering control measures (e.g., enclosure or confinement of the operation, general and local ventilation) or administrative control measures (e.g., workplace policies and procedures) shall be considered and implemented to prevent exposure, where feasible. 
(ii) Hazard communication. 
Requirements as specified in § 721.72(a) through (e), (g)(1), (g)(2)(i) through (iii) and (v), (g)(3)(i) and (ii), and (g)(5). For purposes of § 721.72(e), the concentration is set at 1.0%. For purposes of § 721.72(g)(1), this substance may cause: Acute toxicity; skin sensitization; serious eye damage; specific target organ toxicity; neurotoxicity; genetic toxicity; reproductive toxicity. Alternative hazard and warning statements that meet the criteria of the Globally Harmonized System and OSHA Hazard Communication Standard may be used. 
(iii) Industrial, commercial, and 
consumer activities. Requirements as specified in § 721.80(f), (k), and (t). It is a significant new use to import the substance in any physical state other than in solution, unless in sealed containers weighing 5 kilograms or less. It is a significant new use to process the substance in any way that generates a dust, mist, or aerosol in a non-enclosed process. It is a significant new use to manufacture the substance longer than 18 months. 
(b) Specific requirements. The 
provisions of subpart A of this part 
VerDate Sep<11>2014 15:55 Dec 09, 2021 Jkt 256001 PO 00000 Frm 00053 Fmt 4700 Sfmt 4700 E:\FR\FM\10DER1.SGM 10DER1jspears on DSK121TN23PROD with RULES170402 Federal Register / Vol. 86, No. 235 / Friday, December 10, 2021 / Rules and Regulations 
apply to this section except as modified 
by this paragraph (b). 
(1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125(a) through (i) are applicable to manufacturers and processors of this substance. 
(2) Limitation or revocation of certain 
notification requirements. The provisions of § 721.185 apply to this section. 
(3) Determining whether a specific use 
is subject to this section. The provisions of § 721.1725(b)(1) apply to paragraph (a)(2)(iii) of this section. 
§ 721.11538 Sulfonium, 
bis(dihalocarbomonocycle) carbomonocycle, substituted carbomonocyclic ester (generic). 
(a) Chemical substance and 
significant new uses subject to reporting. 
(1) The chemical substance identified generically as sulfonium, bis(dihalocarbomonocycle) carbomonocycle, substituted carbomonocyclic ester (PMN P–19–115) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. The requirements of this section do not apply to quantities of the substance after they have been completely reacted or adhered (during the photolithographic process) onto a semiconductor wafer surface or similar manufactured article used in the production of semiconductor technologies. 
(2) The significant new uses are: 
(i) Protection in the workplace. 
Requirements as specified in 
§ 721.63(a)(1), (a)(2)(i) and (iii), (a)(3), and (c). When determining which persons are reasonably likely to be exposed as required for § 721.63(a)(1), engineering control measures (e.g., enclosure or confinement of the operation, general and local ventilation) or administrative control measures (e.g., workplace policies and procedures) shall be considered and implemented to prevent exposure, where feasible. 
(ii) Hazard communication. 
Requirements as specified in § 721.72(a) through (e), (g)(1), (g)(2)(i) through (iii) and (v), (g)(3)(i) and (ii), and (g)(5). For purposes of § 721.72(e), the concentration is set at 1.0%. For purposes of § 721.72(g)(1), this substance may cause: Acute toxicity; skin sensitization; serious eye damage; specific target organ toxicity; neurotoxicity; genetic toxicity; reproductive toxicity. Alternative hazard and warning statements that meet the criteria of the Globally Harmonized System and OSHA Hazard Communication Standard may be used. (iii) Industrial, commercial, and 
consumer activities. Requirements as specified in § 721.80(f), (k), and (t). It is a significant new use to import the substance in any physical state other than in solution, unless in sealed containers weighing 5 kilograms or less. It is a significant new use to process the substance in any way that generates a dust, mist, or aerosol in a non-enclosed process. It is a significant new use to manufacture the substance longer than 18 months. 
(b) Specific requirements. The 
provisions of subpart A of this part apply to this section except as modified by this paragraph (b). 
(1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125(a) through (i) are applicable to manufacturers and processors of this substance. 
(2) Limitation or revocation of certain 
notification requirements. The provisions of § 721.185 apply to this section. 
(3) Determining whether a specific use 
is subject to this section. The provisions of § 721.1725(b)(1) apply to paragraph (a)(2)(iii) of this section. 
§ 721.11539 Heteropolycycle, aromatic-, 
salt with dihalo-substituted alkyl carbopolycycle carboxylate (1:1) (generic). 
(a) Chemical substance and 
significant new uses subject to reporting. 
(1) The chemical substance identified generically as heteropolycycle, aromatic-, salt with dihalo-substituted alkyl carbopolycycle carboxylate (1:1) (PMN P–19–142) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. The requirements of this section do not apply to quantities of the substance after they have been completely reacted or adhered (during the photolithographic process) onto a semiconductor wafer surface or similar manufactured article used in the production of semiconductor technologies. 
(2) The significant new uses are: 
(i) Protection in the workplace. 
Requirements as specified in 
§ 721.63(a)(1), (a)(2)(i) and (iii), (a)(3), and (c). When determining which persons are reasonably likely to be exposed as required for § 721.63(a)(1), engineering control measures (e.g., enclosure or confinement of the operation, general and local ventilation) or administrative control measures (e.g., workplace policies and procedures) shall be considered and implemented to prevent exposure, where feasible. 
(ii) Hazard communication. 
Requirements as specified in § 721.72(a) through (e), (g)(1), (g)(2)(i) through (iii) and (v), (g)(3)(i) and (ii), and (g)(5). For purposes of § 721.72(e), the concentration is set at 1.0%. For purposes of § 721.72(g)(1), this substance may cause: Acute toxicity; skin sensitization; serious eye damage; specific target organ toxicity; neurotoxicity; genetic toxicity; reproductive toxicity. Alternative hazard and warning statements that meet the criteria of the Globally Harmonized System and OSHA Hazard Communication Standard may be used. 
(iii) Industrial, commercial, and 
consumer activities. Requirements as specified in § 721.80(f), (k), and (t). It is a significant new use to import the substance in any physical state other than in solution, unless in sealed containers weighing 5 kilograms or less. It is a significant new use to process the substance in any way that generates a dust, mist, or aerosol in a non-enclosed process. It is a significant new use to manufacture the substance longer than 18 months. 
(b) Specific requirements. The 
provisions of subpart A of this part apply to this section except as modified by this paragraph (b). 
(1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125(a) through (i) are applicable to manufacturers and processors of this substance. 
(2) Limitation or revocation of certain 
notification requirements. The provisions of § 721.185 apply to this section. 
(3) Determining whether a specific use 
is subject to this section. The provisions of § 721.1725(b)(1) apply to paragraph (a)(2)(iii) of this section. 
§ 721.11540 Triarylsulfonium 
alkylestersulfonate (generic). 
(a) Chemical substance and 
significant new uses subject to reporting. 
(1) The chemical substance identified generically as triarylsulfonium alkylestersulfonate (PMN P–19–166) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. The requirements of this section do not apply to quantities of the substance after they have been completely reacted or adhered (during the photolithographic process) onto a semiconductor wafer surface or similar manufactured article used in the production of semiconductor technologies. 
(2) The significant new uses are: 
(i) Protection in the workplace. 
Requirements as specified in 
§ 721.63(a)(1), (a)(2)(i) and (iii), (a)(3), and (c). When determining which persons are reasonably likely to be exposed as required for § 721.63(a)(1), 
VerDate Sep<11>2014 15:55 Dec 09, 2021 Jkt 256001 PO 00000 Frm 00054 Fmt 4700 Sfmt 4700 E:\FR\FM\10DER1.SGM 10DER1jspears on DSK121TN23PROD with RULES170403 Federal Register / Vol. 86, No. 235 / Friday, December 10, 2021 / Rules and Regulations 
engineering control measures (e.g., 
enclosure or confinement of the operation, general and local ventilation) or administrative control measures (e.g., workplace policies and procedures) shall be considered and implemented to prevent exposure, where feasible. 
(ii) Hazard communication. 
Requirements as specified in § 721.72(a) through (e), (g)(1), (g)(2)(i) through (iii) and (v), (g)(3)(i) and (ii), and (g)(5). For purposes of § 721.72(e), the concentration is set at 1.0%. For purposes of § 721.72(g)(1), this substance may cause: Acute toxicity; skin sensitization; serious eye damage; specific target organ toxicity; neurotoxicity; genetic toxicity; reproductive toxicity. 
(iii) Industrial, commercial, and 
consumer activities. Requirements as specified in § 721.80(f), (k), and (t). It is a significant new use to import the substance in any physical state other than in solution, unless in sealed containers weighing 5 kilograms or less. It is a significant new use to use or process the substance in any way that generates a dust, mist, or aerosol in a non-enclosed process. It is a significant new use to manufacture the substance longer than 18 months. 
(b) Specific requirements. The 
provisions of subpart A of this part apply to this section except as modified by this paragraph (b). 
(1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125(a) through (i) are applicable to manufacturers and processors of this substance. 
(2) Limitation or revocation of certain 
notification requirements. The provisions of § 721.185 apply to this section. 
(3) Determining whether a specific use 
is subject to this section. The provisions of § 721.1725(b)(1) apply to paragraph (a)(2)(iii) of this section. 
§ 721.11541 Halogenated alkylbenzoic acid 
(generic) (P–19–168). 
(a) Chemical substance and 
significant new uses subject to reporting. 
(1) The chemical substance identified generically as halogenated alkylbenzoic acid (PMN P–19–168) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. 
(2) The significant new uses are: 
(i) Protection in the workplace. 
Requirements as specified in 
§ 721.63(a)(1), (a)(2)(i), (iii), and (iv), (a)(3) through (6), (b), and (c). When determining which persons are reasonably likely to be exposed as required for § 721.63(a)(1) and (a)(4), engineering control measures (e.g., enclosure or confinement of the operation, general and local ventilation) or administrative control measures (e.g., workplace policies and procedures) shall be considered and implemented to prevent exposure, where feasible. For purposes of § 721.63(a)(5), respirators must provide a National Institute for Occupational Safety and Health (NIOSH) assigned protection factor (APF) of at least 10. For purposes of § 721.63(a)(6), the airborne form(s) of the substance include particulate, gas/ vapor (all substances in the gas form), combination gas/vapor and particulate (gas and liquid/solid physical states are present; a good example is paint spray mist, which contains both liquid droplets and vapor). For purposes of § 721.63(b), the concentration is set at 1.0%. 
(A) As an alternative to the respirator 
requirements in paragraph (a)(2)(i) of this section, a manufacturer or processor may choose to follow the new chemical exposure limit (NCEL) provision listed in the TSCA Order for this substance. The NCEL is 0.0195 mg/m
3as an 8-hour 
time weighted average. Persons who wish to pursue NCELs as an alternative to § 721.63 respirator requirements may request to do so under § 721.30. Persons whose § 721.30 requests to use the NCELs approach that are approved by EPA will be required to follow NCELs provisions comparable to those contained in the corresponding TSCA Order. 
(B) [Reserved] 
(ii) Hazard communication. 
Requirements as specified in § 721.72(a) 
through (f) and (g)(1), (2), and (5). For purposes of § 721.72(e), the concentration is set at 1.0%. For purposes of § 721.72(g)(1), this substance may cause: Skin irritation; eye irritation; respiratory complications; central nervous system effects; internal organ effects; reproductive effects; developmental effects. For purposes of § 721.72(g)(2), when using this substance: Avoid skin contact; avoid breathing the substance; avoid ingestion; use respiratory protection or maintain workplace airborne concentrations at or below an 8-hour time-weighted average of 0.0195 mg/m
3; 
use skin protection. Alternative hazard and warning statements that meet the criteria of the Globally Harmonized System and OSHA Hazard Communication Standard may be used. 
(iii) Industrial, commercial, and 
consumer activities. Requirements as specified in § 721.80(k), (q), and (t). It is a significant new use to manufacture or process the substance without implementing the engineering controls/ processes described in the TSCA Order for the substance. 
(b) Specific requirements. The 
provisions of subpart A of this part apply to this section except as modified by this paragraph (b). 
(1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125(a) through (i) are applicable to manufacturers and processors of this substance. 
(2) Limitation or revocation of certain 
notification requirements. The provisions of § 721.185 apply to this section. 
(3) Determining whether a specific use 
is subject to this section. The provisions of § 721.1725(b)(1) apply to paragraph (a)(2)(iii) of this section. 
§ 721.11542 Halogenated alkylbenzoic acid 
(generic) (P–19–169). 
(a) Chemical substance and 
significant new uses subject to reporting. 
(1) The chemical substance identified generically as halogenated alkylbenzoic acid (PMN P–19–169) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. 
(2) The significant new uses are: 
(i) Protection in the workplace. 
Requirements as specified in 
§ 721.63(a)(1), (a)(2)(i), (iii), and (iv), (a)(3) through (6), (b), and (c). When determining which persons are reasonably likely to be exposed as required for § 721.63(a)(1) and (a)(4), engineering control measures (e.g., enclosure or confinement of the operation, general and local ventilation) or administrative control measures (e.g., workplace policies and procedures) shall be considered and implemented to prevent exposure, where feasible. For purposes of § 721.63(a)(5), respirators must provide a National Institute for Occupational Safety and Health (NIOSH) assigned protection factor (APF) of at least 10. For purposes of § 721.63(a)(6), the airborne form(s) of the substance include particulate, gas/ vapor (all substances in the gas form), combination gas/vapor and particulate (gas and liquid/solid physical states are present; a good example is paint spray mist, which contains both liquid droplets and vapor). For purposes of § 721.63(b), the concentration is set at 1.0%. 
(A) As an alternative to the respirator 
requirements in paragraph (a)(2)(i) of this section, a manufacturer or processor may choose to follow the new chemical exposure limit (NCEL) provision listed in the TSCA Order for this substance. The NCEL is 0.0195 mg/m
3as an 8-hour 
time weighted average. Persons who wish to pursue NCELs as an alternative 
VerDate Sep<11>2014 15:55 Dec 09, 2021 Jkt 256001 PO 00000 Frm 00055 Fmt 4700 Sfmt 4700 E:\FR\FM\10DER1.SGM 10DER1jspears on DSK121TN23PROD with RULES170404 Federal Register / Vol. 86, No. 235 / Friday, December 10, 2021 / Rules and Regulations 
to § 721.63 respirator requirements may 
request to do so under § 721.30. Persons whose § 721.30 requests to use the NCELs approach that are approved by EPA will be required to follow NCELs provisions comparable to those contained in the corresponding TSCA Order. 
(B) [Reserved] 
(ii) Hazard communication. 
Requirements as specified in § 721.72(a) 
through (f) and (g)(1), (2), and (5). For purposes of § 721.72(e), the concentration is set at 1.0%. For purposes of § 721.72(g)(1), this substance may cause: Skin irritation; eye irritation; respiratory complications; central nervous system effects; internal organ effects; reproductive effects; developmental effects. For purposes of § 721.72(g)(2), when using this substance: Avoid skin contact; avoid breathing the substance; avoid ingestion; use respiratory protection or maintain workplace airborne concentrations at or below an 8-hour time-weighted average of 0.0195 mg/m
3; 
use skin protection. Alternative hazard and warning statements that meet the criteria of the Globally Harmonized System and OSHA Hazard Communication Standard may be used. 
(iii) Industrial, commercial, and 
consumer activities. Requirements as specified in § 721.80(k), (q), and (t). It is a significant new use to manufacture or process the substance without implementing the engineering controls/ processes described in the TSCA Order for the substance. 
(b) Specific requirements. The 
provisions of subpart A of this part apply to this section except as modified by this paragraph (b). 
(1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125(a) through (i) are applicable to manufacturers and processors of this substance. 
(2) Limitation or revocation of certain 
notification requirements. The provisions of § 721.185 apply to this section. 
(3) Determining whether a specific use 
is subject to this section. The provisions of § 721.1725(b)(1) apply to paragraph (a)(2)(iii) of this section. 
§ 721.11543 Halogenated benzoic acid 
(generic) (P–19–171). 
(a) Chemical substance and 
significant new uses subject to reporting. 
(1) The chemical substance identified generically as halogenated benzoic acid (PMN P–19–171) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. 
(2) The significant new uses are: (i) Protection in the workplace. 
Requirements as specified in § 721.63(a)(1), (a)(2)(i), (iii), and (iv), (a)(3) through (6), (b), and (c). When determining which persons are reasonably likely to be exposed as required for § 721.63(a)(1) and (a)(4), engineering control measures (e.g., enclosure or confinement of the operation, general and local ventilation) or administrative control measures (e.g., workplace policies and procedures) shall be considered and implemented to prevent exposure, where feasible. For purposes of § 721.63(a)(5), respirators must provide a National Institute for Occupational Safety and Health (NIOSH) assigned protection factor (APF) of at least 10. For purposes of § 721.63(a)(6), the airborne form(s) of the substance include particulate, gas/ vapor (all substances in the gas form), combination gas/vapor and particulate (gas and liquid/solid physical states are present; a good example is paint spray mist, which contains both liquid droplets and vapor). For purposes of § 721.63(b), the concentration is set at 1.0%. 
(A) As an alternative to the respirator 
requirements in paragraph (a)(2)(i) of this section, a manufacturer or processor may choose to follow the new chemical exposure limit (NCEL) provision listed in the TSCA Order for this substance. The NCEL is 0.0195 mg/m
3as an 8-hour 
time weighted average. Persons who wish to pursue NCELs as an alternative to § 721.63 respirator requirements may request to do so under § 721.30. Persons whose § 721.30 requests to use the NCELs approach that are approved by EPA will be required to follow NCELs provisions comparable to those contained in the corresponding TSCA Order. 
(B) [Reserved] 
(ii) Hazard communication. 
Requirements as specified in § 721.72(a) 
through (f) and (g)(1), (2), and (5). For purposes of § 721.72(e), the concentration is set at 1.0%. For purposes of § 721.72(g)(1), this substance may cause: Skin irritation; eye irritation; respiratory complications; central nervous system effects; internal organ effects; reproductive effects; developmental effects. For purposes of § 721.72(g)(2), when using this substance: Avoid skin contact; avoid breathing the substance; avoid ingestion; use respiratory protection or maintain workplace airborne concentrations at or below an 8-hour time-weighted average of 0.0195 mg/m
3; 
use skin protection. Alternative hazard and warning statements that meet the criteria of the Globally Harmonized System and OSHA Hazard Communication Standard may be used. 
(iii) Industrial, commercial, and 
consumer activities. Requirements as specified in § 721.80(k), (q), and (t). It is a significant new use to manufacture or process the substance without implementing the engineering controls/ processes described in the TSCA Order for the substance. 
(b) Specific requirements. The 
provisions of subpart A of this part apply to this section except as modified by this paragraph (b). 
(1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125(a) through (i) are applicable to manufacturers and processors of this substance. 
(2) Limitation or revocation of certain 
notification requirements. The provisions of § 721.185 apply to this section. 
(3) Determining whether a specific use 
is subject to this section. The provisions of § 721.1725(b)(1) apply to paragraph (a)(2)(iii) of this section. 
§ 721.11544 Halogenated benzoic acid 
(generic) (P–19–172). 
(a) Chemical substance and 
significant new uses subject to reporting. 
(1) The chemical substance identified generically as halogenated benzoic acid (PMN P–19–172) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. 
(2) The significant new uses are: 
(i) Protection in the workplace. 
Requirements as specified in 
§ 721.63(a)(1), (a)(2)(i), (iii), and (iv), (a)(3) through (6), (b), and (c). When determining which persons are reasonably likely to be exposed as required for § 721.63(a)(1) and (a)(4), engineering control measures (e.g., enclosure or confinement of the operation, general and local ventilation) or administrative control measures (e.g., workplace policies and procedures) shall be considered and implemented to prevent exposure, where feasible. For purposes of § 721.63(a)(5), respirators must provide a National Institute for Occupational Safety and Health (NIOSH) assigned protection factor (APF) of at least 10. For purposes of § 721.63(a)(6), the airborne form(s) of the substance include particulate, gas/ vapor (all substances in the gas form), combination gas/vapor and particulate (gas and liquid/solid physical states are present; a good example is paint spray mist, which contains both liquid droplets and vapor). For purposes of § 721.63(b), the concentration is set at 1.0%. 
VerDate Sep<11>2014 15:55 Dec 09, 2021 Jkt 256001 PO 00000 Frm 00056 Fmt 4700 Sfmt 4700 E:\FR\FM\10DER1.SGM 10DER1jspears on DSK121TN23PROD with RULES170405 Federal Register / Vol. 86, No. 235 / Friday, December 10, 2021 / Rules and Regulations 
(A) As an alternative to the respirator 
requirements in paragraph (a)(2)(i) of 
this section, a manufacturer or processor may choose to follow the new chemical exposure limit (NCEL) provision listed in the TSCA Order for this substance. The NCEL is 0.0195 mg/m
3as an 8-hour 
time weighted average. Persons who wish to pursue NCELs as an alternative to § 721.63 respirator requirements may request to do so under § 721.30. Persons whose § 721.30 requests to use the NCELs approach that are approved by EPA will be required to follow NCELs provisions comparable to those contained in the corresponding TSCA Order. 
(B) [Reserved] 
(ii) Hazard communication. 
Requirements as specified in § 721.72(a) 
through (f) and (g)(1), (2), and (5). For purposes of § 721.72(e), the concentration is set at 1.0%. For purposes of § 721.72(g)(1), this substance may cause: Skin irritation; eye irritation; respiratory complications; central nervous system effects; internal organ effects; reproductive effects; developmental effects. For purposes of § 721.72(g)(2), when using this substance: Avoid skin contact; avoid breathing the substance; avoid ingestion; use respiratory protection or maintain workplace airborne concentrations at or below an 8-hour time-weighted average of 0.0195 mg/m
3; 
use skin protection. Alternative hazard and warning statements that meet the criteria of the Globally Harmonized System and OSHA Hazard Communication Standard may be used. 
(iii) Industrial, commercial, and 
consumer activities. Requirements as specified in § 721.80(k), (q), and (t). It is a significant new use to manufacture or process the substance without implementing the engineering controls/ processes described in the TSCA Order for the substance. 
(b) Specific requirements. The 
provisions of subpart A of this part apply to this section except as modified by this paragraph (b). 
(1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125(a) through (i) are applicable to manufacturers and processors of this substance. 
(2) Limitation or revocation of certain 
notification requirements. The provisions of § 721.185 apply to this section. 
(3) Determining whether a specific use 
is subject to this section. The provisions of § 721.1725(b)(1) apply to paragraph (a)(2)(iii) of this section. § 721.11545 Halogenated benzoic acid 
(generic) (P–19–173). 
(a) Chemical substance and 
significant new uses subject to reporting. 
(1) The chemical substance identified generically as halogenated benzoic acid (PMN P–19–173) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. 
(2) The significant new uses are: 
(i) Protection in the workplace. 
Requirements as specified in 
§ 721.63(a)(1), (a)(2)(i), (iii), and (iv), (a)(3) through (6), (b), and (c). When determining which persons are reasonably likely to be exposed as required for § 721.63(a)(1) and (a)(4), engineering control measures (e.g., enclosure or confinement of the operation, general and local ventilation) or administrative control measures (e.g., workplace policies and procedures) shall be considered and implemented to prevent exposure, where feasible. For purposes of § 721.63(a)(5), respirators must provide a National Institute for Occupational Safety and Health (NIOSH) assigned protection factor (APF) of at least 10. For purposes of § 721.63(a)(6), the airborne form(s) of the substance include particulate, gas/ vapor (all substances in the gas form), combination gas/vapor and particulate (gas and liquid/solid physical states are present; a good example is paint spray 
mist, which contains both liquid droplets and vapor). For purposes of § 721.63(b), the concentration is set at 1.0%. 
(A) As an alternative to the respirator 
requirements in paragraph (a)(2)(i) of this section, a manufacturer or processor may choose to follow the new chemical exposure limit (NCEL) provision listed in the TSCA Order for this substance. The NCEL is 0.0195 mg/m
3as an 8-hour 
time weighted average. Persons who wish to pursue NCELs as an alternative to § 721.63 respirator requirements may request to do so under § 721.30. Persons whose § 721.30 requests to use the NCELs approach that are approved by EPA will be required to follow NCELs provisions comparable to those contained in the corresponding TSCA Order. 
(B) [Reserved] 
(ii) Hazard communication. 
Requirements as specified in § 721.72(a) 
through (f) and (g)(1), (2), and (5). For purposes of § 721.72(e), the concentration is set at 1.0%. For purposes of § 721.72(g)(1), this substance may cause: Skin irritation; eye irritation; respiratory complications; central nervous system effects; internal organ effects; reproductive effects; developmental effects. For purposes of § 721.72(g)(2), when using this substance: Avoid skin contact; avoid breathing the substance; avoid ingestion; use respiratory protection or maintain workplace airborne concentrations at or below an 8-hour time-weighted average of 0.0195 mg/m
3; 
use skin protection. Alternative hazard and warning statements that meet the criteria of the Globally Harmonized System and OSHA Hazard Communication Standard may be used. 
(iii) Industrial, commercial, and 
consumer activities. Requirements as specified in § 721.80(k), (q), and (t). It is a significant new use to manufacture or process the substance without implementing the engineering controls/ processes described in the TSCA Order for the substance. 
(b) Specific requirements. The 
provisions of subpart A of this part apply to this section except as modified by this paragraph (b). 
(1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125(a) through (i) are applicable to manufacturers and processors of this substance. 
(2) Limitation or revocation of certain 
notification requirements. The provisions of § 721.185 apply to this section. 
(3) Determining whether a specific use 
is subject to this section. The provisions of § 721.1725(b)(1) apply to paragraph (a)(2)(iii) of this section. 
§ 721.11546 Halogenated alkylbenzoic acid 
(generic) (P–19–175). 
(a) Chemical substance and 
significant new uses subject to reporting. 
(1) The chemical substance identified generically as halogenated alkylbenzoic acid (PMN P–19–175) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. 
(2) The significant new uses are: 
(i) Protection in the workplace. 
Requirements as specified in 
§ 721.63(a)(1), (a)(2)(i), (iii), and (iv), (a)(3) through (6), (b), and (c). When determining which persons are reasonably likely to be exposed as required for § 721.63(a)(1) and (a)(4), engineering control measures (e.g., enclosure or confinement of the operation, general and local ventilation) or administrative control measures (e.g., workplace policies and procedures) shall be considered and implemented to prevent exposure, where feasible. For purposes of § 721.63(a)(5), respirators must provide a National Institute for Occupational Safety and Health (NIOSH) assigned protection factor (APF) of at least 10. For purposes of § 721.63(a)(6), the airborne form(s) of 
VerDate Sep<11>2014 15:55 Dec 09, 2021 Jkt 256001 PO 00000 Frm 00057 Fmt 4700 Sfmt 4700 E:\FR\FM\10DER1.SGM 10DER1jspears on DSK121TN23PROD with RULES170406 Federal Register / Vol. 86, No. 235 / Friday, December 10, 2021 / Rules and Regulations 
the substance include particulate, gas/ 
vapor (all substances in the gas form), combination gas/vapor and particulate (gas and liquid/solid physical states are present; a good example is paint spray mist, which contains both liquid droplets and vapor). For purposes of § 721.63(b), the concentration is set at 1.0%. 
(A) As an alternative to the respirator 
requirements in paragraph (a)(2)(i) of this section, a manufacturer or processor may choose to follow the new chemical exposure limit (NCEL) provision listed in the TSCA Order for this substance. The NCEL is 0.0195 mg/m
3as an 8-hour 
time weighted average. Persons who wish to pursue NCELs as an alternative to § 721.63 respirator requirements may request to do so under § 721.30. Persons whose § 721.30 requests to use the NCELs approach that are approved by EPA will be required to follow NCELs provisions comparable to those contained in the corresponding TSCA Order. 
(B) [Reserved] 
(ii) Hazard communication. 
Requirements as specified in § 721.72(a) 
through (f) and (g)(1), (2), and (5). For purposes of § 721.72(e), the concentration is set at 1.0%. For purposes of § 721.72(g)(1), this substance may cause: Skin irritation; eye irritation; respiratory complications; central nervous system effects; internal organ effects; reproductive effects; developmental effects. For purposes of § 721.72(g)(2), when using this substance: Avoid skin contact; avoid breathing the substance; avoid ingestion; use respiratory protection or maintain workplace airborne concentrations at or below an 8-hour time-weighted average of 0.0195 mg/m
3; 
use skin protection. Alternative hazard and warning statements that meet the criteria of the Globally Harmonized System and OSHA Hazard Communication Standard may be used. 
(iii) Industrial, commercial, and 
consumer activities. Requirements as specified in § 721.80(k), (q), and (t). It is a significant new use to manufacture or process the substance without implementing the engineering controls/ processes described in the TSCA Order for the substance. 
(b) Specific requirements. The 
provisions of subpart A of this part apply to this section except as modified by this paragraph (b). 
(1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125(a) through (i) are applicable to manufacturers and processors of this substance. 
(2) Limitation or revocation of certain 
notification requirements. The provisions of § 721.185 apply to this section. 
(3) Determining whether a specific use 
is subject to this section. The provisions of § 721.1725(b)(1) apply to paragraph (a)(2)(iii) of this section. 
§ 721.11547 Halogenated alkylbenzoic acid 
(generic) (P–19–176). 
(a) Chemical substance and 
significant new uses subject to reporting. 
(1) The chemical substance identified generically as halogenated alkylbenzoic acid (PMN P–19–176) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. 
(2) The significant new uses are: 
(i) Protection in the workplace. 
Requirements as specified in 
§ 721.63(a)(1), (a)(2)(i), (iii), and (iv), (a)(3) through (6), (b), and (c). When determining which persons are reasonably likely to be exposed as required for § 721.63(a)(1) and (a)(4), engineering control measures (e.g., enclosure or confinement of the operation, general and local ventilation) or administrative control measures (e.g., workplace policies and procedures) shall be considered and implemented to prevent exposure, where feasible. For purposes of § 721.63(a)(5), respirators must provide a National Institute for Occupational Safety and Health (NIOSH) assigned protection factor (APF) of at least 10. For purposes of § 721.63(a)(6), the airborne form(s) of the substance include particulate, gas/ vapor (all substances in the gas form), combination gas/vapor and particulate. For purposes of § 721.63(b), the concentration is set at 1.0%. 
(A) As an alternative to the respirator 
requirements in paragraph (a)(2)(i) of this section, a manufacturer or processor may choose to follow the new chemical exposure limit (NCEL) provision listed in the TSCA Order for this substance. The NCEL is 0.0195 mg/m
3as an 8-hour 
time weighted average. Persons who wish to pursue NCELs as an alternative to § 721.63 respirator requirements may request to do so under § 721.30. Persons whose § 721.30 requests to use the NCELs approach that are approved by EPA will be required to follow NCELs provisions comparable to those contained in the corresponding TSCA Order. 
(B) [Reserved] 
(ii) Hazard communication. 
Requirements as specified in § 721.72(a) 
through (f) and (g)(1), (2), and (5). For purposes of § 721.72(e), the concentration is set at 1.0%. For purposes of § 721.72(g)(1), this substance may cause: Respiratory complications; central nervous system effects; internal organ effects; skin irritation; eye irritation; acute toxicity; skin sensitization; serious eye damage; specific target organ toxicity; neurotoxicity; genetic toxicity; reproductive toxicity. For purposes of § 721.72(g)(2), when using this substance: Avoid skin contact; avoid breathing substance; avoid ingestion; use skin protection; use respiratory protection or maintain workplace airborne concentrations at or below an 8-hour time-weighted average of 0.0195 mg/m
3; use skin protection. Alternative 
hazard and warning statements that meet the criteria of the Globally Harmonized System and OSHA Hazard Communication Standard may be used. 
(iii) Industrial, commercial, and 
consumer activities. Requirements as specified in § 721.80(k), (q), and (t). It is a significant new use to manufacture or process the substance without implementing the engineering controls/ processes described in the TSCA Order for the substance. 
(b) Specific requirements. The 
provisions of subpart A of this part apply to this section except as modified by this paragraph (b). 
(1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125(a) through (i) are applicable to manufacturers and processors of this substance. 
(2) Limitation or revocation of certain 
notification requirements. The provisions of § 721.185 apply to this section. 
(3) Determining whether a specific use 
is subject to this section. The provisions of § 721.1725(b)(1) apply to paragraph (a)(2)(iii) of this section. 
§ 721.11548 Halogenated alkylbenzoic acid 
(generic) (P–19–177). 
(a) Chemical substance and 
significant new uses subject to reporting. 
(1) The chemical substance identified generically as halogenated alkylbenzoic acid (PMN P–19–177) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. 
(2) The significant new uses are: 
(i) Protection in the workplace. 
Requirements as specified in 
§ 721.63(a)(1), (a)(2)(i), (iii), and (iv), (a)(3) through (6), (b), and (c). When determining which persons are reasonably likely to be exposed as required for § 721.63(a)(1) and (a)(4), engineering control measures (e.g., enclosure or confinement of the operation, general and local ventilation) or administrative control measures (e.g., workplace policies and procedures) shall be considered and implemented to prevent exposure, where feasible. For 
VerDate Sep<11>2014 15:55 Dec 09, 2021 Jkt 256001 PO 00000 Frm 00058 Fmt 4700 Sfmt 4700 E:\FR\FM\10DER1.SGM 10DER1jspears on DSK121TN23PROD with RULES170407 Federal Register / Vol. 86, No. 235 / Friday, December 10, 2021 / Rules and Regulations 
purposes of § 721.63(a)(5), respirators 
must provide a National Institute for Occupational Safety and Health (NIOSH) assigned protection factor (APF) of at least 10. For purposes of § 721.63(a)(6), the airborne form(s) of the substance include particulate, gas/ vapor (all substances in the gas form), combination gas/vapor and particulate (gas and liquid/solid physical states are present; a good example is paint spray mist, which contains both liquid droplets and vapor). For purposes of § 721.63(b), the concentration is set at 1.0%. 
(A) As an alternative to the respirator 
requirements in paragraph (a)(2)(i) of this section, a manufacturer or processor may choose to follow the new chemical exposure limit (NCEL) provision listed in the TSCA Order for this substance. The NCEL is 0.0195 mg/m
3as an 8-hour 
time weighted average. Persons who wish to pursue NCELs as an alternative to § 721.63 respirator requirements may request to do so under § 721.30. Persons whose § 721.30 requests to use the NCELs approach that are approved by EPA will be required to follow NCELs provisions comparable to those contained in the corresponding TSCA Order. 
(B) [Reserved] 
(ii) Hazard communication. 
Requirements as specified in § 721.72(a) 
through (f) and (g)(1), (2), and (5). For purposes of § 721.72(e), the concentration is set at 1.0%. For purposes of § 721.72(g)(1), this substance may cause: Skin irritation; eye irritation; respiratory complications; central nervous system effects; internal organ effects; reproductive effects; developmental effects. For purposes of § 721.72(g)(2), when using this substance: Avoid skin contact; avoid breathing the substance; avoid ingestion; use respiratory protection or maintain workplace airborne concentrations at or below an 8-hour time-weighted average of 0.0195 mg/m
3; 
use skin protection. Alternative hazard and warning statements that meet the criteria of the Globally Harmonized System and OSHA Hazard Communication Standard may be used. 
(iii) Industrial, commercial, and 
consumer activities. Requirements as specified in § 721.80(k), (q), and (t). It is a significant new use to manufacture or process the substance without implementing the engineering controls/ processes described in the TSCA Order for the substance. 
(b) Specific requirements. The 
provisions of subpart A of this part apply to this section except as modified by this paragraph (b). (1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125(a) through (i) are applicable to manufacturers and processors of this substance. 
(2) Limitation or revocation of certain 
notification requirements. The provisions of § 721.185 apply to this section. 
(3) Determining whether a specific use 
is subject to this section. The provisions of § 721.1725(b)(1) apply to paragraph (a)(2)(iii) of this section. 
§ 721.11549 Halogenated alkylbenzoic acid 
(generic) (P–19–178). 
(a) Chemical substance and 
significant new uses subject to reporting. 
(1) The chemical substance identified generically as halogenated alkylbenzoic acid (PMN P–19–178) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. 
(2) The significant new uses are: 
(i) Protection in the workplace. 
Requirements as specified in 
§ 721.63(a)(1), (a)(2)(i), (iii), and (iv), (a)(3) through (6), (b), and (c). When determining which persons are reasonably likely to be exposed as required for § 721.63(a)(1) and (a)(4), engineering control measures (e.g., enclosure or confinement of the operation, general and local ventilation) or administrative control measures (e.g., workplace policies and procedures) shall be considered and implemented to prevent exposure, where feasible. For purposes of § 721.63(a)(5), respirators must provide a National Institute for Occupational Safety and Health (NIOSH) assigned protection factor (APF) of at least 10. For purposes of § 721.63(a)(6), the airborne form(s) of the substance include particulate, gas/ vapor (all substances in the gas form), combination gas/vapor and particulate (gas and liquid/solid physical states are present; a good example is paint spray mist, which contains both liquid droplets and vapor). For purposes of § 721.63(b), the concentration is set at 1.0%. 
(A) As an alternative to the respirator 
requirements in paragraph (a)(2)(i) of this section, a manufacturer or processor may choose to follow the new chemical exposure limit (NCEL) provision listed in the TSCA Order for this substance. The NCEL is 0.0195 mg/m
3as an 8-hour 
time weighted average. Persons who wish to pursue NCELs as an alternative to § 721.63 respirator requirements may request to do so under § 721.30. Persons whose § 721.30 requests to use the NCELs approach that are approved by EPA will be required to follow NCELs provisions comparable to those contained in the corresponding TSCA Order. 
(B) [Reserved] 
(ii) Hazard communication. 
Requirements as specified in § 721.72(a) 
through (f) and (g)(1), (2), and (5). For purposes of § 721.72(e), the concentration is set at 1.0%. For purposes of § 721.72(g)(1), this substance may cause: Skin irritation; eye irritation; respiratory complications; central nervous system effects; internal organ effects; reproductive effects; developmental effects. For purposes of § 721.72(g)(2), when using this substance: Avoid skin contact; avoid breathing the substance; avoid ingestion; use respiratory protection or maintain workplace airborne concentrations at or below an 8-hour time-weighted average of 0.0195 mg/m
3; 
use skin protection. Alternative hazard and warning statements that meet the criteria of the Globally Harmonized System and OSHA Hazard Communication Standard may be used. 
(iii) Industrial, commercial, and 
consumer activities. Requirements as specified in § 721.80(k), (q), and (t). It is a significant new use to manufacture or process the substance without implementing the engineering controls/ processes described in the TSCA Order for the substance. 
(b) Specific requirements. The 
provisions of subpart A of this part apply to this section except as modified by this paragraph (b). 
(1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125(a) through (i) are applicable to manufacturers and processors of this substance. 
(2) Limitation or revocation of certain 
notification requirements. The provisions of § 721.185 apply to this section. 
(3) Determining whether a specific use 
is subject to this section. The provisions of § 721.1725(b)(1) apply to paragraph (a)(2)(iii) of this section. 
§ 721.11550 Halogenated alkylbenzoic acid 
(generic) (P–19–179). 
(a) Chemical substance and 
significant new uses subject to reporting. 
(1) The chemical substance identified generically as halogenated alkylbenzoic acid (PMN P–19–179) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. 
(2) The significant new uses are: 
(i) Protection in the workplace. 
Requirements as specified in 
§ 721.63(a)(1), (a)(2)(i), (iii), and (iv), (a)(3) through (6), (b), and (c). When determining which persons are reasonably likely to be exposed as 
VerDate Sep<11>2014 15:55 Dec 09, 2021 Jkt 256001 PO 00000 Frm 00059 Fmt 4700 Sfmt 4700 E:\FR\FM\10DER1.SGM 10DER1jspears on DSK121TN23PROD with RULES170408 Federal Register / Vol. 86, No. 235 / Friday, December 10, 2021 / Rules and Regulations 
required for § 721.63(a)(1) and (a)(4), 
engineering control measures (e.g., enclosure or confinement of the operation, general and local ventilation) or administrative control measures (e.g., workplace policies and procedures) shall be considered and implemented to prevent exposure, where feasible. For purposes of § 721.63(a)(5), respirators must provide a National Institute for Occupational Safety and Health (NIOSH) assigned protection factor (APF) of at least 10. For purposes of § 721.63(a)(6), the airborne form(s) of the substance include particulate, gas/ vapor (all substances in the gas form), combination gas/vapor and particulate (gas and liquid/solid physical states are present; a good example is paint spray mist, which contains both liquid droplets and vapor). For purposes of § 721.63(b), the concentration is set at 1.0%. 
(A) As an alternative to the respirator 
requirements in paragraph (a)(2)(i) of this section, a manufacturer or processor may choose to follow the new chemical exposure limit (NCEL) provision listed in the TSCA Order for this substance. The NCEL is 0.0195 mg/m
3as an 8-hour 
time weighted average. Persons who wish to pursue NCELs as an alternative to § 721.63 respirator requirements may request to do so under § 721.30. Persons whose § 721.30 requests to use the NCELs approach that are approved by EPA will be required to follow NCELs provisions comparable to those contained in the corresponding TSCA Order. 
(B) [Reserved] 
(ii) Hazard communication. 
Requirements as specified in § 721.72(a) 
through (f) and (g)(1), (2), and (5). For purposes of § 721.72(e), the concentration is set at 1.0%. For purposes of § 721.72(g)(1), this substance may cause: Skin irritation; eye irritation; respiratory complications; central nervous system effects; internal organ effects; reproductive effects; developmental effects. For purposes of 
§ 721.72(g)(2), when using this substance: Avoid skin contact; avoid breathing the substance; avoid ingestion; use respiratory protection or maintain workplace airborne concentrations at or below an 8-hour time-weighted average of 0.0195 mg/m
3; 
use skin protection. Alternative hazard and warning statements that meet the criteria of the Globally Harmonized System and OSHA Hazard Communication Standard may be used. 
(iii) Industrial, commercial, and 
consumer activities. Requirements as specified in § 721.80(k), (q), and (t). It is a significant new use to manufacture or process the substance without implementing the engineering controls/ processes described in the TSCA Order for the substance. 
(b) Specific requirements. The 
provisions of subpart A of this part apply to this section except as modified by this paragraph (b). 
(1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125(a) through (i) are applicable to manufacturers and processors of this substance. 
(2) Limitation or revocation of certain 
notification requirements. The provisions of § 721.185 apply to this section. 
(3) Determining whether a specific use 
is subject to this section. The provisions of § 721.1725(b)(1) apply to paragraph (a)(2)(iii) of this section. 
§ 721.11551 Halogenated sodium benzoate 
(generic) (P–19–180). 
(a) Chemical substance and 
significant new uses subject to reporting. 
(1) The chemical substance identified generically as halogenated sodium benzoate (PMN P–19–180) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. 
(2) The significant new uses are: 
(i) Hazard communication. 
Requirements as specified in § 721.72(a) 
through (f), (g)(1), (g)(2)(i) through (iii), and (g)(5). For purposes of § 721.72(e), the concentration is set at 1.0%. For purposes of § 721.72(g)(1), this substance may cause: Skin irritation; eye irritation; respiratory complications; central nervous system effects; internal organ effects; reproductive effects; developmental effects. Alternative hazard and warning statements that meet the criteria of the Globally Harmonized System and OSHA Hazard Communication Standard may be used. 
(ii) Industrial, commercial, and 
consumer activities. Requirements as specified in § 721.80(k) and (q). It is a significant new use to manufacture or process the substance without implementing the engineering controls/ processes described in the TSCA Order for the substance. It is a significant new use to manufacture or use the substance other than in liquid formulations. 
(b) Specific requirements. The 
provisions of subpart A of this part apply to this section except as modified by this paragraph (b). 
(1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125(a) through (c) and (f) through (i) are applicable to manufacturers and processors of this substance. 
(2) Limitation or revocation of certain 
notification requirements. The provisions of § 721.185 apply to this section. 
(3) Determining whether a specific use 
is subject to this section. The provisions of § 721.1725(b)(1) apply to paragraph (a)(2)(ii) of this section. 
§ 721.11552 Halogenated sodium benzoate 
(generic) (P–19–181). 
(a) Chemical substance and 
significant new uses subject to reporting. 
(1) The chemical substance identified generically as halogenated sodium benzoate (PMN P–19–181) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. 
(2) The significant new uses are: 
(i) Hazard communication. 
Requirements as specified in § 721.72(a) 
through (f), (g)(1), (g)(2)(i) through (iii), and (g)(5). For purposes of § 721.72(e), the concentration is set at 1.0%. For purposes of § 721.72(g)(1), this substance may cause: Skin irritation; eye irritation; respiratory complications; central nervous system effects; internal organ effects; reproductive effects; developmental effects. Alternative hazard and warning statements that meet the criteria of the Globally Harmonized System and OSHA Hazard Communication Standard may be used. 
(ii) Industrial, commercial, and 
consumer activities. Requirements as specified in § 721.80(k) and (q). It is a significant new use to manufacture or process the substance without implementing the engineering controls/ processes described in the TSCA Order for the substance. It is a significant new use to manufacture or use the substance other than in liquid formulations. 
(b) Specific requirements. The 
provisions of subpart A of this part apply to this section except as modified by this paragraph (b). 
(1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125(a) through (c) and (f) through (i) are applicable to manufacturers and processors of this substance. 
(2) Limitation or revocation of certain 
notification requirements. The provisions of § 721.185 apply to this section. 
(3) Determining whether a specific use 
is subject to this section. The provisions of § 721.1725(b)(1) apply to paragraph (a)(2)(ii) of this section. 
§ 721.11553 Halogenated sodium benzoate 
(generic) (P–19–182). 
(a) Chemical substance and 
significant new uses subject to reporting. 
(1) The chemical substance identified generically as halogenated sodium benzoate (PMN P–19–182) is subject to reporting under this section for the 
VerDate Sep<11>2014 15:55 Dec 09, 2021 Jkt 256001 PO 00000 Frm 00060 Fmt 4700 Sfmt 4700 E:\FR\FM\10DER1.SGM 10DER1jspears on DSK121TN23PROD with RULES170409 Federal Register / Vol. 86, No. 235 / Friday, December 10, 2021 / Rules and Regulations 
significant new uses described in 
paragraph (a)(2) of this section. 
(2) The significant new uses are: 
(i) Hazard communication. 
Requirements as specified in § 721.72(a) 
through (f), (g)(1), (g)(2)(i) through (iii), and (g)(5). For purposes of § 721.72(e), the concentration is set at 1.0%. For purposes of § 721.72(g)(1), this substance may cause: Skin irritation; eye irritation; respiratory complications; central nervous system effects; internal organ effects; reproductive effects; developmental effects. Alternative hazard and warning statements that meet the criteria of the Globally Harmonized System and OSHA Hazard Communication Standard may be used. 
(ii) Industrial, commercial, and 
consumer activities. Requirements as specified in § 721.80(k) and (q). It is a significant new use to manufacture or process the substance without implementing the engineering controls/ processes described in the TSCA Order for the substance. It is a significant new use to manufacture or use the substance other than in liquid formulations. 
(b) Specific requirements. The 
provisions of subpart A of this part apply to this section except as modified by this paragraph (b). 
(1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125(a) through (c) and (f) through (i) are applicable to manufacturers and processors of this substance. 
(2) Limitation or revocation of certain 
notification requirements. The provisions of § 721.185 apply to this section. 
(3) Determining whether a specific use 
is subject to this section. The provisions of § 721.1725(b)(1) apply to paragraph (a)(2)(ii) of this section. 
§ 721.11554 Halogenated sodium 
alkylbenzoate (generic) (P–19–184). 
(a) Chemical substance and 
significant new uses subject to reporting. 
(1) The chemical substance identified generically as halogenated sodium alkylbenzoate (PMN P–19–184) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. 
(2) The significant new uses are: 
(i) Hazard communication. 
Requirements as specified in § 721.72(a) 
through (f), (g)(1), (g)(2)(i) through (iii), and (g)(5). For purposes of § 721.72(e), the concentration is set at 1.0%. For purposes of § 721.72(g)(1), this substance may cause: Skin irritation; eye irritation; respiratory complications; central nervous system effects; internal organ effects; reproductive effects; developmental effects. Alternative hazard and warning statements that meet the criteria of the Globally Harmonized System and OSHA Hazard Communication Standard may be used. 
(ii) Industrial, commercial, and 
consumer activities. Requirements as specified in § 721.80(k) and (q). It is a significant new use to manufacture or process the substance without implementing the engineering controls/ processes described in the TSCA Order for the substance. It is a significant new use to manufacture or use the substance other than in liquid formulations. 
(b) Specific requirements. The 
provisions of subpart A of this part apply to this section except as modified by this paragraph (b). 
(1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125(a) through (c) and (f) through (i) are applicable to manufacturers and processors of this substance. 
(2) Limitation or revocation of certain 
notification requirements. The provisions of § 721.185 apply to this section. 
(3) Determining whether a specific use 
is subject to this section. The provisions of § 721.1725(b)(1) apply to paragraph (a)(2)(ii) of this section. 
§ 721.11555 Halogenated sodium 
alkylbenzoate (generic) (P–19–187). 
(a) Chemical substance and 
significant new uses subject to reporting. 
(1) The chemical substance identified generically as halogenated sodium alkylbenzoate (PMN P–19–187) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. 
(2) The significant new uses are: 
(i) Hazard communication. 
Requirements as specified in § 721.72(a) 
through (f), (g)(1), (g)(2)(i) through (iii), and (g)(5). For purposes of § 721.72(e), the concentration is set at 1.0%. For purposes of § 721.72(g)(1), this substance may cause: Skin irritation; eye irritation; respiratory complications; central nervous system effects; internal organ effects; reproductive effects; developmental effects. Alternative hazard and warning statements that meet the criteria of the Globally Harmonized System and OSHA Hazard Communication Standard may be used. 
(ii) Industrial, commercial, and 
consumer activities. Requirements as specified in § 721.80(k) and (q). It is a significant new use to manufacture or process the substance without implementing the engineering controls/ processes described in the TSCA Order for the substance. It is a significant new use to manufacture or use the substance other than in liquid formulations. 
(b) Specific requirements. The 
provisions of subpart A of this part apply to this section except as modified by this paragraph (b). 
(1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125(a) through (c) and (f) through (i) are applicable to manufacturers and processors of this substance. 
(2) Limitation or revocation of certain 
notification requirements. The provisions of § 721.185 apply to this section. 
(3) Determining whether a specific use 
is subject to this section. The provisions of § 721.1725(b)(1) apply to paragraph (a)(2)(ii) of this section. 
* * * * * 
[FR Doc. 2021–26683 Filed 12–9–21; 8:45 am] 
BILLING CODE 6560–50–P 
ENVIRONMENTAL PROTECTION 
AGENCY 
40 CFR Part 52 
[EPA–R01–OAR–2021–0580; FRL–8967–02– 
R1] 
Air Plan Approval; Rhode Island; 2015 
Ozone NAAQS Interstate Transport Requirements 
AGENCY : Environmental Protection 
Agency (EPA). 
ACTION : Final rule. 
SUMMARY : The Environmental Protection 
Agency (EPA) is approving a State Implementation Plan (SIP) revision submitted by the State of Rhode Island as meeting the Clean Air Act (CAA) requirement that each State’s SIP contain adequate provisions to prohibit emissions that will significantly contribute to nonattainment or interfere with maintenance of the 2015 8-hour ozone national ambient air quality standards (NAAQS) in any other state. This action is being taken in accordance with the CAA. 
DATES : This rule is effective on January 
10, 2022. 
ADDRESSES : EPA has established a 
docket for this action under Docket Identification No. EPA–R01–OAR– 2021–0580. All documents in the docket are listed on the https://www.regulations.gov website. Although 
listed in the index, some information is not publicly available, i.e., confidential 
business information (CBI) or other information whose disclosure is restricted by statute. Certain other material, such as copyrighted material, is not placed on the internet and will be publicly available only in hard copy form. Publicly available docket materials are available at https://www.regulations.gov or at the U.S. 
VerDate Sep<11>2014 15:55 Dec 09, 2021 Jkt 256001 PO 00000 Frm 00061 Fmt 4700 Sfmt 4700 E:\FR\FM\10DER1.SGM 10DER1jspears on DSK121TN23PROD with RULES1